ABSTRACT
Hibiscus rosa‐sinensis , commonly known as the shoe flower, thrives in tropical and subtropical regions across South China, Asia, Africa, and America, adapting well to diverse environments. Its therapeutic potential is attributed to a range of bioactive compounds Anthocyanins, saponins, quercetin, kaempferol, and anthraquinones are found in various plant parts. These compounds scavenge reactive oxygen and nitrogen species and modulate inflammatory (IL‐6, TNF‐α, PPAR‐γ, cyclooxygenase) and oxidative (MDA, MPO, NO, SOD, GSH) markers, offering therapeutic benefits against cancer, diabetes, cardiovascular, neurological, gastrointestinal, and hepato‐renal disorders. The plant exhibits antidiabetic effects by lowering blood glucose, triglycerides, cholesterol, and postprandial glucose absorption. Cardioprotective properties are linked to the regulation of PPAR‐γ, SREBP‐1c, acetyl‐CoA carboxylase, and fatty acid synthase. Molecular docking studies reveal strong binding affinities of myricetin and rutin with α‐glucosidase (−10.5) and SOD (−8.6), highlighting their antidiabetic and hepatoprotective potential. H. rosa‐sinensis also exhibits antimicrobial activity against various bacterial (e.g., E. coli , S. aureus ) and fungal strains (e.g., A. flavus , A. niger ). Animal‐based studies affirm its safety between 400 and 800 mg/kg body weight. Its coloring, flavoring, nutritional, and therapeutic properties support applications in food, cosmetics, nutraceuticals, and dyeing. However, long‐term clinical trials are essential to validate its traditional uses and therapeutic efficacy.
Keywords: antioxidant, Hibiscus rosa‐sinensis , molecular docking, phytochemistry
H. rosa‐sinensis bioactives modulate oxidative and inflammatory pathways. Myricetin and rutin show strong α‐glucosidase and SOD binding affinity. Exhibits safe, multifunctional use in health, food and nutraceuticals.

Abbreviations
- ABTS
2,2'‐azino‐bis‐(3‐ethylbenzothiazoline‐6‐sulfonic) acid
- AIDS
acquired immunodeficiency syndrome
- ALP
alkaline phosphatase
- ALT
alanine transaminase
- AMPK
AMP‐activated protein kinase
- AST
aspartate transferase
- C3
carbon 3
- CAT
catalase
- CCL4
carbon tetrachloride
- CD4
cluster of differentiation 4
- CMC
carboxy methyl cellulose
- CuO NPs
copper oxide nanoparticles
- DPPH
2,2‐diphenyl‐1‐picrylhydrazyl
- ESR1
estrogen receptor 1
- FRAP
ferric reducing antioxidant power
- GABA
gamma‐Aminobutyric acid
- GAE
gallic acid equivalents
- GSH
glutathione
- HCT
hematocrit
- HDL
high density lipoprotein
- HER2
human epidermal growth factor receptor 2
- HIV
human immunodeficiency virus
- IgE
immunoglobulin E
- IL‐6
interleukin 6
- LD
lethal dose
- LDL
low density lipoprotein
- MCF
Michigan Cancer Foundation
- MDA
malondialdehyde
- MIC
minimum inhibitory concentration
- MPO
myeloperoxidase
- MTT
3‐ (4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide
- NO
nitric oxide
- PDB
protein data bank
- PPAR‐γ
peroxisome proliferator‐activated receptor gamma
- PRISMA
Preferred Reporting Items for Systematic reviews and Meta‐Analyses
- ROS's
reactive oxygen species
- SOD
superoxide dismutase
- SREBP‐1c
Sterol regulatory element binding protein‐1c
- TC
total cholesterol
- TFC
total flavonoid content
- TG
triglyceride
- TNF‐α
tumor necrosis factor alpha
- TPC
total phenolic content
- VLDL
very low‐density lipoprotein
1. Introduction
The medicinal herbs and flowers have changed the aura of the 21st century and shifted global trends towards natural herbal remedies due to their pharmacological aspects. The development of ethnomedicine and nutraceuticals has significantly impacted humanity and plays a key role in health promotion (Chaachouay and Zidane 2024). Multiple communities from ancient times have used plants for various purposes, including food, shelter, and earning sources, based on their knowledge, skills, and beliefs (Zemede et al. 2024). Moreover, these flowers and herbs are the backbone of traditional healthcare systems and have been used for centuries to cure several acute and chronic disorders (Ralte et al. 2024). Despite modern commercialized synthetic drugs that are available in the market and have immediate responses to manage the symptoms of diseases, more than 80% of the current world population uses medicinal plants as primary treatment sources (Yadav et al. 2024).
Several adverse health consequences, such as gastrointestinal disturbance, neurological impairments, and heart and renal failure, have been reported from the utilization of synthetic drugs (Rehman et al. 2024). According to the World Health Organization, ~5 million individuals die each year due to improper and false drug recommendations. These figures demanded the formulation of such drugs, which have limited adverse health effects and better health benefits (Ahmed et al. 2024). Nutraceutical and food industrialists have developed nutraceuticals and functional foods that modulate the normal physiology of the human body (Keservani et al. 2024; Shi et al. 2024).
Medicinal plants and their compounds are safe to consume with multiple health‐promoting and disease‐reducing properties. H. rosa‐sinensis , an evergreen herbaceous medicinal plant, belongs to the Malvaceae family and Hibiscus genus that has around 275 species in tropical and subtropical regions of the world (Raza et al. 2025; Geeganage and Gunathilaka 2024). H. rosa‐sinensis is renowned for its diverse nomenclature across the world's various regions. It is Gul‐e‐Gurhal in Pakistan, Chembarathi in Malayalam, Semparutti in Tamil, Rudrapuspa in Sanskrit, Gurhal in Hindi, Shoe flower plant and Chinese hibiscus in English (Sivaraman and Saju 2021). Flavonoids and polyphenolic compounds present in H. rosa‐sinensis are responsible for its anti‐inflammatory, antitumorigenic, antibacterial, antifungal, anti‐diabetic, antioxidant, and antipyretic properties (Sanadheera et al. 2021).
This multidimensional review focuses on the nutritional composition and phytochemistry of H. rosa‐sinensis . It effectively conveys that the content goes far beyond ornamental uses, highlighting H. rosa‐sinensis's medicinal properties, safety concerns, and the industrial value of different parts. Moreover, the studies on the synergy of H. rosa‐sinensis with other medicinal plants are the highlight of this article. The combination of health, safety, and economic perspectives ensures relevance across disciplines, making this review unique and impactful. Lastly, this review is the first to comprehensively report molecular docking regarding hepatoprotective and antidiabetic roles, offering new insights into the therapeutic potential of H. rosa‐sinensis.
2. Methodology
As shown in the PRISMA flow diagram (Figure 1), 300 studies were found. After removing duplicates and excluding irrelevant papers based on titles and abstracts, 195 articles were retained for full‐text review. Fifteen articles were excluded after full‐text review, with the reasons for their removal detailed in the PRISMA flow diagram. Finally, 180 studies were included in the review.
FIGURE 1.

PRISMA flow diagram of the literature search process.
3. Taxonomical Classification
| Kingdom | Plantae |
| Subkingdom | Tracheobionta |
| Division | Magnoliophyta |
| Class | Magnoliopsida |
| Subclass | Dilleniidae |
| Order | Malvaceae |
| Genus | Hibiscus |
| Species | H. rosa‐sinensis |
(Iqbal and Rehman 2023).
4. Geographical Distribution
H. rosa‐sinensis is an herbal flowering plant distributed across the world's tropical and subtropical regions, particularly in South China, tropical Asia, Africa, and America, which provides favorable conditions for its growth and germination. However, its growth depends on soil fertility, nutrient availability, irrigation system, and environmental and climatic conditions (Magdalita and San Pascual 2022; Shah and Wu 2019).
5. Botanical and Morphological Description
H. rosa‐sinensis is a perennial shrub that grows to a height of 1.3 m with a width of 1.5–2.4 m. Its dull green leaves are simple, serrate, and glabrous, with a length of 4 to 8 cm and a width of 2 cm. Its flowers are five‐petalled with a 4‐in. diameter and are bisexual, showy, actinomorphic, dichlamydeous, and pentamerous. The seeds aid in the germination process of H. rosa‐sinensis , which occurs because of pollination in appropriate environmental conditions. It has abortive fruit, erect and cylindrical stems, and branched tap roots, while its dark brown seeds are 1.6 to 2.9 mm tall. Its growth is at its peak when the temperature is optimum, i.e., 13°C–34°C, and pH is about 5.5–6. Its cultivation is significantly increased due to its pest, disease, and drought‐resistant properties (Shaheen et al. 2023; Valdivié and Martínez 2022). The botanical and morphological description of H. rosa‐sinensis is demonstrated in Figure 2.
FIGURE 2.

Botanical description of Hibiscus rosa‐sinensis.
6. Nutritional Composition
The nutritional profile of H. rosa‐sinensis significantly contributes to improving healthy lifestyles and overall well‐being. Different factors such as biofortification, enrichment, and fermentation can improve the nutritional profile and enhance the bioavailability of nutrients within the body (Moyo 2024). Studies have reported that nutrient content can vary depending on environmental factors. It has been found that the moisture (2.6%–7.7%), ash (3%–14%), fat (2%–9%), fiber (3.1%–3.9%), proteins (2%–7%), and carbohydrate contents are (32%–73%), respectively in the leaves of H. rosa‐sinensis (Eze and Nwibo 2017; Udo et al. 2016). However, the flowers of H. rosa‐sinensis have moisture (76%–83%), ash (5.5%–6.3%), fats (0.3%–1.2%), fiber (1.5%–2%), proteins (1.54%–2.4%), and carbohydrates (13%–15%) (Bala et al. 2022; Al‐Snafi 2018). Vitamins such as vitamin A (2.5), vitamin B2 (1.5), vitamin C (20), vitamin E (10 mg/100 g) and minerals including potassium (5.4), iron (9.5), calcium (9.3 mg/100 g), phosphorous (42 mg/g‐1), sodium (0.4 mg/g‐1), magnesium (90 mg/g‐1), and manganese (2.4 mg/g‐1) are the main micro‐constituents of dried leaves of H. rosa‐sinensis (Eze and Nwibo 2017; Udo et al. 2016).
7. Phytochemical Composition
H. rosa‐sinensis contains several bioactive compounds that impose multiple therapeutic attributes and contribute to improving individuals' health. Shafiq et al. (2021) identified caffeic acid, gallic acid, and p‐coumaric acid at 15, 11, and 35 ppm concentrations. Furthermore, the bioactive compounds in the roots are (flavonoids, tannins, glycosides, resins, reducing sugars, saponins, gums and mucilage) (Amtaghri et al. 2024), leaves (alkaloids, quercetin, kaempferol, anthocyanins, sterols, glycosides, and fats) (Umar et al. 2024), stems (sitosterol, cardiac glycosides, anthraquinones, malvalic acids and cyclic sterculic acid) (Tawfeeq et al. 2024), and flowers (thiamine, riboflavin, niacin, apigenidine, oxalic, citric and ascorbic acids) (Zulkurnain et al. 2023; Bala et al. 2022).
The essential oil extracted from the flowers contains bioactive compounds such as 1‐iodoundecane, 1, 2‐benzenedicarboxylic acid isodecyl octyl ester, neopentane, 2‐propenamide, 1–4 butanediol ester, 2, 2, 4‐trimethyl 3‐pentanone, 2‐cyclopentylethanol, 1‐tetrazole‐2‐ylethanone, amyl nitrite, and 4‐trifluoroacetoxyoctane (Agarwal and Prakash 2013). The essential oil of H. rosa‐sinensis leaves comprises limonene, carvone, tetradecane, (E)‐caryophyllene, 2‐ethylhexyl mercaptoacetate, bisabolene, caryophyllene oxide, 1,3,7,11‐cyclotetradecatetraene, dibutyl phthalate, docosyl heptafluorobutyrate, and squalene, performing multiple functions within the body systems (Sidhu et al. 2023). The chemical structures of H. rosa‐sinensis bioactive compounds are drawn below.
8. Traditional Applications
H. rosa‐sinensis has been traditionally used in primary healthcare systems to cure multiple disorders. Healthcare professionals formulate different decoctions, amalgams, and creams using parts of H. rosa‐sinensis against specific ailments. These formulations vary from region to region. Bangladesh prepares decoctions by using the flowers of H. rosa‐sinensis to modulate the regular menstrual cycles. At the same time, the Chinese formulate hot water extract from their flowers and bark to regulate menstrual periods and reduce menstrual pain. In addition to menstruation regulation, H. rosa‐sinensis also contains other traditional health implementations (Bala et al. 2022). The hot water extracts of its dried leaves and flowers are used to treat sick infants, gonorrhea, influenza, dry and productive cough, stimulate labor during delivery, and bronchitis. Its roots and bark are beneficial in the management of sexually transmitted disorders (HIV and AIDS), cough, skin disorders, and menorrhagia (Amtaghri et al. 2024; Magdalita and San Pascual 2022; De Boer and Cotingting 2014). Table 1 includes the traditional uses of H. rosa‐sinensis different parts in various regions of the world (Bala et al. 2022).
TABLE 1.
Traditional uses of H. rosa‐sinensis different parts in different forms throughout the world.
| Parts | Form/route | Uses/benefits | Country |
|---|---|---|---|
| Flower | Hot water extract | Emmenagogue | China |
| Leaves and flowers | Sick infants | Cook Islands | |
| Leaves and flowers | Gonorrhea | Cook Islands | |
| Flowers | Reproductive issues | East indies | |
| Flowers | Grippe | French Guiana | |
| Root and bark | External emollients | Philippines | |
| Flowers | Regulate menstruation | New Britain (East) | |
| Dried stems | Contraceptive and emmenagogue | Peru | |
| Flowers and leaves | Ease childbirth | Fiji | |
| Leaves | Fresh juice | Diarrhea and improves reproductivity | Fiji |
| Fresh leaves | Decoction | Antidiarrheal | Japan |
| Flowers | Orally | Emmenagogue and aphrodisiac | Kuwait |
| Roselle juice | Juice | To quench thirst | Thailand |
| Bark | Extract | Emmenagogue | Vietnam |
| Bark, stem | Decoction | Menorrhagia | Vanuata |
| Leaves | Eaten as spinach | Food | Nyasaland in South Africa |
| Fresh flowers | Infusion (orally) | Abortifacient | Rarotonga |
| Flowers and leaves | Water extract | Induce labor | Samoa |
| Young leaves | Water (orally) | Induce labor | Ireland |
| Flower and bark | Infusions | Treatment of dysentery | Mexico |
9. Medicinal Properties
H. rosa‐sinensis has various health‐promoting and disease‐ameliorating properties, which are mainly due to the presence of bioactive constituents. These components aid in alleviating the progression and severity of different health disorders such as diabetes, cardiovascular disorders, liver cirrhosis, and arthritis.
9.1. Antioxidant Potential
The antioxidant potential of plants is their ability to scavenge and neutralize ROS, thus helping reduce oxidative stress and inflammation and maintaining homeostasis in the body (Goyal et al. 2025). Although synthetic antioxidants have been prepared, due to their low effectiveness, natural antioxidants are frequently used to reduce free radicals (Uzombah 2022). The capacity of H. rosa‐sinensis to scavenge and neutralize ROS makes it a suitable option as a natural antioxidant. Various studies have been conducted to validate the antioxidant properties of H. rosa‐sinensis. The antioxidant activity of H. rosa‐sinensis' isolated compounds (C3, C4, and C5) and vitamin C was evaluated by determining ABTS scavenging activity, lipid peroxidation scavenging activity, metal chelating activity, nitric oxide scavenging activity, superoxide scavenging activity, and hydrogen peroxide scavenging activity which demonstrated that compound C5 has higher free radical scavenging activity as compared to C3, C4, and ascorbic acid. The respective EC50 values were 2.82, 4.70, 5.22, 6.57, 8.10, and 5.19 μg/mL (Rengarajan et al. 2020). Earlier, Thi et al. (2021) revealed the antioxidant potential of H. rosa‐sinensis by conducting a DPPH assay at varying concentrations of 0.05%, 0.1%, 0.15%, 0.2%, 0.25%, and 0.3%. The results depicted the maximum DPPH free radical's inhibitory effect (87.42%) at 0.3% concentration compared to other concentrations.
Moreover, Sidhu et al. (2023) conducted DPPH, NO, and ABTS assays to assess the antioxidant potential of H. rosa‐sinensis leaves essential oil and dibutyl phthalate. It was observed that the essential oil has more antioxidant potential with IC50 values of 1240 μg/mL (DPPH), 1300 μg/mL (NO), and 1460 μg/mL (ABTS). The DPPH assay revealed that the methanolic extract of H. rosa‐sinensis leaf and flowers was revealed by Sharma and Thakur (2022) with respective IC50 values of 98 and 117 μg/mL. Similarly, its ethanolic leaf extract showed free radical scavenging potential as determined by the DPPH method with the IC50 value of 18.70 μg/mL (Kumar Dwivedi and Jain 2023). Ghaffar and El‐Elaimy (2012) conducted total antioxidant activity and reducing power assays, which revealed that H. rosa‐sinensis extract has a significant free radical scavenging effect compared to butylated hydroxytoluene at 500 μg/mL. Furthermore, Khan et al. (2014) demonstrated the free radical scavenging potential of H. rosa‐sinensis flowers, which showed DPPH inhibition of 75.4% and 64.9% by its methanol and ethanol extracts, respectively.
Additionally, Falade et al. (2009) indicated DPPH inhibition by the methanolic extract of flowers, which was 43.9 mg/mL. The observed DPPH inhibition was 83% and 97% by the ethanol and aqueous extract of Hibiscus flower (Mak et al. 2013). Chai (2020) evaluated the free‐radical scavenging potential of white, orange, and hybrid hibiscus flowers and leaves by conducting DPPH, TPC, TFC, and FRAP assays. It has been shown that orange flowers have the highest antioxidant potential (90%) as compared to white (81%) and hybrid (75%) Hibiscus, with the respective values of DPPH (90.45%), TPC (33 mg GAE/g), and FRAP (125.38 mg FE/g). Similarly, Kumar Dwivedi and Jain (2023) revealed that the ethanol extract of hibiscus leaves has the highest antioxidant potential with an IC50 value of 18.70 μg/mL.
9.2. Anticancer Activity
Cancer is a proliferative disorder that rapidly spreads and disrupts the normal growth of cells. Cancer prevalence constantly increases with advancements in food, environment, industries, and healthcare facilities (Johariya et al. 2024). According to an estimation, approximately 20 million cases of cancer were reported in 2024, with 9.7 million fatalities. These figures demand effective management strategies with limited toxic effects to reduce mortality and cancer prevalence (Noman et al. 2025). Researchers have employed a medicinal plant, H. rosa‐sinensis , to evaluate the cancer‐ameliorating potential. Harini (2024) conducted a trial to investigate the anticancer potential of H. rosa‐sinensis by MTT assay, and it was demonstrated that the ethanolic extract of hibiscus (10, 25, 50 μg/mL) showed dose‐dependent attenuation of cancer proliferation and migration. Furthermore, Lu et al. (2022) used H. rosa‐sinensis to synthesize silver (Ag) nanoparticles and determined their impact on the viability of hepatic carcinoma. The results revealed that silver nanoparticles had cytotoxic potential against the invasion, migration, and proliferation of hepatocellular cancer cell lines. The IC50 was 223 μg/mL for SNU‐387, 265 μg/mL for Morris hepatoma (McA‐RH7777), 185 μg/mL for hepatic ductal carcinoma (LMH/2A), and 188 μg/mL for Novikoff hepatoma (N1‐S1 Fudr) cell lines.
H. rosa‐sinensis depicted cytotoxic activity against human liver cancer (Hep G2) cell lines by revealing suppression of 132.49% (Shafiq et al. 2021). Moreover, Akhtar et al. (2022) prepared gold nanoparticles of hibiscus and curcumin extract and conducted a comparative study against cancerous cells (HCT‐116 and MCF‐7). The results demonstrated the higher cytotoxic activity of hibiscus gold nanoparticles with an IC50 of 5.80 μg/mL and 3.62 μg/mL against the migration and proliferation of HCT‐116 and MCF‐7 cells compared to curcumin gold nanoparticles. It has been observed that mutations in the ESR1 and HER2 genes advance the development of breast cancer in females. Therefore, Agrawal et al. (2021) proposed an in silico study to investigate the effect of hibiscus on ESR1 and HER2 in breast cancer management. It has been evident that the bioactive compounds, such as rutin, quercetin, kaempferol, and myricetin, of hibiscus have promising effects on attenuating the impact of ESR1 and HER2; however, among these compounds, rutin has a relatively higher suppressive activity, which acts as an inhibitor of ESR1 and HER2 genes. The prevalence of skin cancer is constantly increasing, which causes 50,000 deaths among individuals all over the world. Melanoma is the principal factor aggravating the pathogenesis of skin cancer. However, effective treatment to manage its etiology is limited. Therefore, alternative and safer techniques for utilizing plants and plant‐based compounds are incorporated into modern trials. Goldberg et al. (2016) investigated the growth inhibitory potential of hibiscus flowers' aqueous extract against B16F10 melanoma cells. The results revealed dose‐dependent suppression of melanoma growth and proliferation by hibiscus supplementation. The findings showed that 1 mg/mL inhibited 2‐fold cell proliferation, while 2 mg/mL reduced 4 times cell growth. Furthermore, Rehana et al. (2017) showed that the copper oxide nanoparticles (CuO NPs) of H. rosa‐sinensis had tumor suppressor potential against MCF‐7, Hep‐2, and A549 cancer cell lines. The findings revealed that CuO–S6 showed maximum inhibitory potential with an IC50 of 19.77 μg/mL against MCF‐7 cell lines, whilst, CuO–S3 and CuO–S6 exhibited IC50s of 21.63, 21.66, and 18.11 μg/mL against HeLa, Hep‐2, and A549 cell lines, respectively.
9.3. Antidiabetic Potential
Diabetes mellitus, especially type 2 diabetes, is rapidly prevailing and affecting every 1 in 9 individuals globally. According to reports, diabetes affects ~450 million individuals above 30 years old residing in low‐ and middle‐income countries, and these counts are progressively increasing from year to year. According to Yu et al. (2024), diabetes not only negatively affects pancreatic activity but also influences other organs of the body, i.e., eyes (diabetic retinopathy), nerves (diabetic neuropathy), kidneys (diabetic nephropathy), and feet (diabetic foot). Therefore, medicinal plants, such as hibiscus, have been implemented in rodent trials to confirm their antidiabetic potential. The α‐amylase suppressive activity was assessed by a calorimetric method to determine the antidiabetic activity of hibiscus, and it has been proven that the hypoglycemic potential of hibiscus was obtained by inhibiting α‐amylase activity (Harini 2024). The neutralizing effect of H. rosa‐sinensis was determined by Sharma et al. (2023) against α‐amylase and α‐glucosidase activity, and it was observed that higher α‐amylase and α‐glucosidase attenuating activity was shown by ethyl acetate extract with IC50 values of 83 μg/mL and 53.33 μg/mL. Previously, Ansari et al. (2020) used the ethanolic extract of H. rosa‐sinensis to investigate the hypoglycemic effect in type 2 diabetic rats. The attenuation in blood glucose, triglycerides, and cholesterol has been observed, along with improved HDL cholesterol and hepatic glycogen, by administering 250/500 mg/kg body weight of H. rosa‐sinensis . Additionally, H. rosa‐sinensis inhibited the HPP‐IV enzyme to significantly improve glucose tolerance by lowering glucose absorption and postprandial hyperglycemia. Studies evidencing the antidiabetic potential of H. rosa‐sinensis are mentioned in Table 2.
TABLE 2.
Antidiabetic and hypoglycemic potential of H. rosa‐sinensis .
| Study | Part used | Extract | Subjects | Dose | Upregulation | Downregulation | References |
|---|---|---|---|---|---|---|---|
| In vitro | Petals | RIN‐m5F pancreatic β‐cells | — | Insulin excretion, Ucn‐3, Pdx‐1, MafA, foxO‐1, and Nkx6.1 expression | NF‐κB translocation | Pillai and Mini (2018) | |
| In vitro | Flowers | Ethyl acetate | 3 T3‐L1 cells | 25 & 50 μg/mL | AMPK, β‐oxidation of fatty acids | Triglycerides, PPAR‐γ, C/EBPα, SREBP‐1c, acetyl‐CoA carboxylase | Lingesh et al. (2019) |
| In vivo | Flowers | Aqueous | Female Wistar rats | 300 mg/kg body weight (BW)/day | Maternal and fetal weight | atherogenic index, coronary artery risk index | Afiune et al. (2017) |
| In vivo | Flower | Ethanol | Streptozotocin induced rats | 250 mg/kg BW | HDL‐cholesterol, insulin release | Blood glucose and insulin levels, cholesterol, triglycerides | Sachdewa and Khemani (2003) |
| In vivo | flowers | Hydroalcoholic | Alloxan‐induced diabetic Wister rats | 50, 100, and 200 mg/kg BW | Size, necrosis and atrophy of Islets cell | Total cholesterol and triglycerides | Pethe, Yelwatkar, Gujar, et al. (2017) |
| In vivo | leaves | Aqueous methanol | Streptozotocin‐induced diabetic rats | 400 mg/kg BW | HDL‐cholesterol, insulin release | LDL‐cholesterol, total cholesterol, triglycerides | Zaki et al. (2017) |
| In vivo | leaves | Ethanol | Alloxan‐infused diabetic rats | 0.5, 1, and 2 mg/kg BW | HDL‐cholesterol | Glucose levels, total cholesterol, triglycerides, LDL‐cholesterol | Mamun et al. (2013) |
| In vivo | Roots | alloxan induced diabetic rats | 500 μg | Insulin secretion | Blood glucose and lipids concentrations, triglycerides | Kumar et al. (2013) | |
| In vivo | flowers | Ethanol | alloxan induced diabetic rabbits | 50, 100, and 200 mg/kg BW | Dyslipidemia | Lipids particularly total cholesterol and triglycerides | Pethe, Yelwatkar, Manchalwar, and Gujar (2017) |
| In vivo | flowers | Aqueous | Streptozotocin induced diabetic rats | 250–500 mg/kg BW | Hypoglycemia | Serum glucose, glycosylated hemoglobin, lipids levels | Bhaskar and Vidhya (2012) |
| In vivo | leaves | Aqueous | Streptozotocin induced diabetic rats | 250 mg per kg BW | Glucose tolerance, hypoglycemia | Blood glucose levels | Sachdewa et al. (2001) |
| In vivo | flowers | Aqueous | Pregnant diabetic rats | 100, 200, and 400 mg/kg BW | Hypolipidemia and hypo‐insulinemia | HDL‐cholesterol, ALT and triglycerides | Silva et al. (2015) |
| In vivo | flowers | Ethanol | Streptozotocin‐induced Wister albino rats | 125 mg/kg BW | Necrosis and degeneration of pancreatic β‐cells | Blood sugar and lipids | Chauhan and Rani (2024a) |
| In vitro and In silico | Flower | Ethyl acetate | — | — | Hypolipidemic effect | α‐glucosidase and α‐ainilase enzymes | Sharma et al. (2023) |
| In vivo | Petals | Acidified methanol | Streptozotocin induced diabetes in male Sprague–Dawley rats | 50 mg/kg BW | Antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, and glutathione) | Glucose, glycated hemoglobin, lipids, oxidative stress | Kalpana et al. (2021) |
| In vivo | Flowers | Aqueous | Streptozotocin‐triggered diabetic rats | 50, 100, 200, and 1000 mg/kg BW | Body weight | IL‐6, IL‐1β, TNF‐α, blood sugar levels | Oluwamodupe et al. (2024) |
9.4. Anti‐Inflammatory and Cardioprotective Properties
Inflammation is the response of immune cells in case any foreign pathogen enters the body. T‐cells play a beneficial role in killing these pathogens, which are involved in the progression of certain inflammatory disorders, i.e., inflammatory bowel disease, multiple sclerosis, diabetes, cancer, autoimmune disorders, cardiovascular disorders, and rheumatoid arthritis. The CD4+ and CD8+ cells differentiate self or foreign proteins, which helps T cells advance their activity (Chen et al. 2024; Mahdy et al. 2024). The comparative study investigated the anti‐inflammatory potential of ethanolic extract of H. rosa‐sinensis var alba (white Hibiscus) and H. rosa‐sinensis L. flowers and leaves by supplementing 5, 50, 100, and 1000 mg/kg extract in carrageenan‐induced paw edema. The results showed significant alleviation of inflammatory markers, particularly cyclooxygenase levels (Guddeti et al. 2015; Raduan et al. 2013).
In another study, Singh et al. (2018) revealed that the tea made from H. rosa‐sinensis has inflammation‐alleviating properties, reducing cartilage destruction and preventing inflammation‐induced arthritis. Previously, Kandhare et al. (2012) investigated the ameliorating potential of Hibiscus leaves' hydroalcoholic extract in acetic acid‐stimulated colitis in male Wistar rats by administering 50, 100, and 200 mg/kg of H. rosa‐sinensis . It has been observed that oxidative stress, MDA, MPO, NO, and TNF‐α reduced while SOD and GSH levels improved by 100 and 200 mg/kg doses of Hibiscus. Similarly, Sruthi et al. (2021) conducted an in vitro study to determine the anti‐inflammatory and anti‐arthritic potential of H. rosa‐sinensis leaves' ethanolic extract. The results depicted that H. rosa‐sinensis stabilizes the membrane (94%) and suppresses protein denaturation (89%) within the specific dose of 500 μg/mL, thereby showing effectiveness against inflammation and arthritis. Moreover, the ethanolic extract of H. rosa‐sinensis roots was employed to investigate the analgesic and anti‐inflammatory potential in carrageenan‐induced paw edema by supplementing 250 and 500 mg/kg root extract and concluded that pain and inflammation were significantly attenuated as the concentration of the extract was increased, revealing a dose‐dependent effect (Begum et al. 2018).
Additionally, Gupta et al. (2014) depicted that the oral supplementation of ~250 mg/kg aqueous root extract of H. rosa‐sinensis ameliorated inflammation in carrageenan‐induced paw edema in Swiss albino rats in a dose‐dependent manner. Gulati (2022) assessed the anti‐inflammatory mechanism of H. rosa‐sinensis and Piper nigrum using a bronchial asthma model and by supplementing 100 and 250 mg/kg H. rosa‐sinensis and 30 and 100 mg/kg Piper nigrum for 2 weeks. Significant reductions in IgE, TNF‐α, and P‐enh levels were observed, and these plants also ameliorated all the blood and bronchoalveolar lavage fluid parameters, ultimately relieving inflammation and bronchospasm in bronchial asthma. The adipogenic potential of H. rosa‐sinensis ethyl acetate flower extract was investigated in 3 T3‐L1 cells by Lingesh et al. (2019), who administered 25 and 50 μg/mL and found the modulated AMP‐activated protein kinase (AMPK), and reduced expression of triglycerides, lipolysis, PPAR‐γ, Sterol regulatory element‐binding protein‐1c (SREBP‐1c), Acetyl‐CoA carboxylase, and fatty acid synthase. Later, Jeevan Kumar and Rajeshkumar (2022) reported the anti‐inflammatory property of silver nanoparticles synthesized from H. rosa‐sinensis , which was 79% at the concentration of 50 μL. A previous study conducted by Somchit et al. (2008) showed that the leaves of H. rosa‐sinensis have dose‐dependent amelioration of prostaglandin D2‐induced inflammation from the paw.
In addition, Gauthaman et al. (2006) conducted a study to assess the potential of 2% CMC‐suspended H. rosa‐sinensis flower against inflammation and oxidative stress‐induced myocardial ischemic reperfusion injury in Wister albino rats of 150–200 g by supplementing hibiscus suspension at the specific dosage of 125, 250, and 500 mg/kg for 6 days a week for 1 month. It has been evident that thiobarbituric acid reactive substances and SOD are significantly improved in the 250 mg/kg administered group, while GSH and CAT levels are relatively alleviated. However, no significant influence was observed in the 125 and 500 mg/kg treated groups.
Previously, Khandelwal et al. (2011) investigated the effect of Hemidesmus indicus and H. rosa‐sinensis at 90, 180, and 360 μg/mL concentrations against ischemia–reperfusion injured rats. Short‐term improvements in left ventricular developed pressure and coronary flow were observed by Hemidesmus indicus. However, H. rosa‐sinensis significantly enhances left ventricular developed pressure and coronary flow, having more vasodilatory, inotropic, and cardioprotective potency than Hemidesmus indicus. In another trial, the impact of anthocyanins from H. rosa‐sinensis against hypertension and deoxycorticosterone acetate‐salt‐induced oxidative stress was evaluated in rats by supplementing 100 and 300 mg/kg hibiscus for a month. The results revealed that the supplementation significantly ameliorated systolic blood pressure, oxidative stress, and vascular reactivity changes (Mohan et al. 2011).
Furthermore, Amtaghri et al. (2022) investigated the hypotensive and vasodilatory potential of H. rosa‐sinensis in hypertensive rats by providing 100 mg/kg aqueous flower extract of H. rosa‐sinensis for 7 days. The results showed that oral consumption of hibiscus flower extract attenuated arterial blood pressure. Moreover, the modulation of angiotensin‐converting enzyme‐2 and the Ca2+ channel suppression pathway promoted vasodilation and ultimately reduced hypertension. The anti‐inflammatory and cardioprotective role of H. rosa‐sinensis is illustrated in Figure 3.
FIGURE 3.

Anti‐inflammatory and Cardioprotective potential of Hibiscus rosa‐sinensis via modulating hypertension, suppressing pro‐inflammatory markers and oxidative stress, inhibiting IgE, improving antioxidant enzymes, and reducing PPAR‐ γ.
9.5. Antimicrobial Properties
Microorganisms are found all over the world with their distinct and versatile nature. Some of them, such as Bifidobacterium and Lactobacillus, have beneficial effects and play their role in improving the health of individuals. Fermentation, the process to enhance and improve the bioavailability of nutrients, is driven by the beneficial microbial population. However, Escherichia coli and Staphylococcus aureus are harmful and pathogenic, causing numerous health disorders. Various antimicrobial drugs are commercially employed to reduce their severity. The antimicrobial attributes of H. rosa‐sinensis have been reported in multiple studies. Chai (2020) evaluated the antibacterial potential of orange, white, and hybrid hibiscus leaves and flowers against Staphylococcus aureus and Escherichia coli . It was observed that the largest zone of inhibition was shown by the hybrid flower (18.67 mm) and the orange flower (16 mm) for the respective bacterial strains, i.e., Staphylococcus aureus and Escherichia coli . In another study, Abate and Belay (2022) investigated the antimicrobial activity of H. rosa‐sinensis against E. coli , S. aureus , K. pneumoniae , and S. epidermidis . The growth inhibitory effect was recorded to be 6.33–11.50 mm for S. aureus and S. epidermidis , while it was 6.67–13 mm against E. coli and K. pneumoniae . Similarly, Ruban and Gajalakshmi (2012) conducted an in vitro study to inquire about the antimicrobial potential of H. rosa‐sinensis flower extract by disc and agar diffusion methods. It has been found that the growth of Bacillus subtilis and Escherichia coli was alleviated by cold extraction of hibiscus with an inhibition zone of 17 and 14.50 mm, respectively. Additionally, the methanol extract of hibiscus showed the maximum bactericidal effect against B. subtilis and E. coli , having a zone of inhibition of 18.86 and 18 mm, respectively. However, the ethanol extract showed the maximum zone of inhibition at 20.40 mm against Salmonella species. Furthermore, using the agar disc diffusion method, Mak et al. (2013) investigated the antibacterial attributes of H. rosa‐sinensis and Senna bicapsularis flower extracts. H. rosa‐sinensis ameliorated the growth of food‐borne pathogens, including Salmonella typhimurium and Staphylococcus aureus , while Senna bicapsularis suppressed the growth of Bacillus cereus and Klebsiella pneumoniae . Further studies regarding the antimicrobial agent of H. rosa‐sinensis are presented in Table 3.
TABLE 3.
Antimicrobial properties of H. rosa‐sinensis .
| Part | Extract/particles | Method | Pathogen/Microorganism | Zone of inhibition | References |
|---|---|---|---|---|---|
| Flowers | Petroleum ether | Disc diffusion | methicillin‐resistant Staphylococcus aureus | 18.6 mm | Arullappan et al. (2009) |
| Flowers | Ethanol and methanol | Agar disc diffusion | Staphylococcus sp., Bacillus sp., and Escherichia coli | 12.75 mm to 16.75 mm | Khan et al. (2014) |
| Leaves | Solvent | Agar disc diffusion | Bacillus subtilis and Staphylococcus aureus | 18.82 mm and 11 mm | Udo et al. (2016) |
| Leaves and flowers | Ethanol | Agar well diffusion and bacteriological enumeration | S. aureus and Salmonella typhimurium | Flowers have more inhibition zone than leaves | Uddin et al. (2010) |
| Flowers | Ethanol & ethyl acetate | 24‐well plates with Brucella agar medium | Helicobacter pylori | MIC = 0.2–0.25 mg/mL | Ngan et al. (2021) |
| Flowers | Iron oxide nanoparticles | Agar well diffusion | Staphylococcus aureus , Pseudomonas aeruginosa , Klebsiella pneumonia, and Escherichia coli | 2 mm to 6 mm | Buarki et al. (2022) |
| Leaves | Zinc oxide and titanium dioxide nanoparticles | Disc diffusion | E. coli and S. aureus | 82.3 mm for E. coli and 54.3 mm for S. aureus | Abd El‐Kader et al. (2021) |
| Leaves and flowers | Ethanol | Agar disc diffusion | Staphylococcus epidermidis , Staphylococcus aureus , and Staphylococcus epidermidis | MIC = 20 mm for Staphylococcus epidermidis , and Staphylococcus aureus , while Minimum Bactericidal Concentration = 20 mg/mL for Staphylococcus epidermidis | Seyyednejad et al. (2010) |
| leaves | CoFe2O4 nanoparticles | Disc diffusion method | S. aureus‐9779 and E. coli‐745 | 8 mm and 12 mm for respective S. aureus‐9779 and E. coli‐745 | Velayutham et al. (2022) |
| Leaves | Silver (Ag) and gold (Au) nanoparticles | Agar well diffusion | Pseudomonas aeruginosa , Bacillus subtilis Micrococcus luteus , Staphylococcus epidermidis , Staphylococcus aureus , Enterobacter aerogenes , Escherichia coli , Streptococcus pneumoniae , and Aeromonas hydrophilia | Inhibition zone (0.04 cm to 0.41 cm) by silver nanoparticles and 0.09 cm to 0.23 cm by gold nanoparticles | Tyagi et al. (2017) |
| Flowers | Aqueous | Agar well diffusion | P. aeruginosa , Serratia, Micrococcus, Enterobacter, and Salmonella | Inhibition zone ranges from 33 mm to 62 mm | Al‐Alak et al. (2015) |
| Leaves | Zinc oxide nanoparticles | Agar well diffusion | Escherichia coli and Staphylococcus aureus | Growth inhibition zone is 35 mm for Escherichia coli and 20 mm for Staphylococcus aureus | Elemike et al. (2021) |
| Leaves | NiSe nanoparticles | Well diffusion | Escherichia coli and Staphylococcus aureus | 10 and 15 mm for the respective Escherichia coli and Staphylococcus aureus | Velayutham et al. (2023) |
| Flowers | Ethanol | Well diffusion | Staphylococcus aureus MTCC 87, Bacillus cereus MTCC 430, Clostridium perfringens MTCC 450, Listeria monocytogenes MTCC 657, Escherichia coli MTCC 43, Salmonella typhi MTCC 1264, and Pseudomonas aeruginosa MTCC424 | 16 mm, 13 mm, 10 mm, 14 mm, 17 mm, 12 mm, and 11 mm for Staphylococcus aureus MTCC 87, Bacillus cereus MTCC 430, Clostridium perfringens MTCC 450, Listeria monocytogenes MTCC 657, Escherichia coli MTCC 43, Salmonella typhi MTCC 1264, and Pseudomonas aeruginosa MTCC424 respectively | Karnwal (2022) |
| Flowers | Silver nanoparticles | Agar well diffusion | A. hydrophila | 16 mm | Surya et al. (2016) |
| Leaves | Aqueous | Well diffusion | Streptococcus pyogenes and Klebsiella pneumoniae | 1.5 and 1.7 cm for the respective Klebsiella pneumoniae and Streptococcus pyogenes | Vignesh and Nair (2018) |
| Flowers | Co3o4 nanoparticles | Diffusion | Staphylococcus aureus , Streptococcus mutans , Klebsilla pneumonia, E. coli , Aspergillus flavus, and Aspergillus niger | — | Anuradha and Raji (2019) |
| Leaves | Ethyl acetate | Agar diffusion | Staphylococcus aureus , Bacillus subtilis , Streptomyces alboniger , Micrococcus luteus , Staphylococcus epidermis, Pseudomonas aeruginosa , and Bordetella bronchiseptica | Orange cultivars revealed MIC values for Staphylococcus aureus (20 mg/mL), Bacillus subtilis (2.5 mg/mL), Streptomyces alboniger (10 mg/mL), Micrococcus luteus (2.5 mg/mL), Staphylococcus epidermis (2.5 mg/mL), Pseudomonas aeruginosa (1.25 mg/mL), and Bordetella bronchiseptica (1.25 mg/mL) | Nagar (2012) |
| Petals | Silver nanoparticles | Disc diffusion | Escherichia coli , Staphylococcus aureus , and Klebsiella pneumonia | E. coli (98%), S. aureus (30%), and K. pneumonia (37%) | Nayak et al. (2015) |
| Flowers | Copper oxide nanoparticles | Well diffusion | Klebsiella pneumoniae , E. coli , Shigella flexneri , and Bacillus subtilis | — | Rajendran et al. (2018) |
| Flowers | Methanol and ethanol | Disc diffusion | Staphylococcus aureus and Escherichia coli | Hybrid flowers showed maximum zone of inhibition (18.67 mm) for Staphylococcus aureus while orange flowers revealed maximum inhibition zone (16 mm) for Escherichia coli | Tong and Tee (2022) |
| Leaves | Ethanol | Agar well diffusion | Streptococcus mutans and Lactobacillus acidophilus | 6.25 μg/mL and 25 μg/mL for S. mutans and L. acidophilus | Nagarajappa et al. (2015) |
| Leaves, flowers, and roots | Methanol and aqueous | Agar well diffusion | Streptococcus aureus | Methanolic leaves extract revealed highest zone of inhibition (29 mm), subsequently methanol flower extract (17 mm), aqueous flower extract (14 mm), and methanolic root extract (13 mm) | Priya and Sharma (2021) |
| Leaves | Aqueous | Agar well diffusion | Escherichia coli , Salmonella typhimurium , Bacillus subtilis , and S. aureus | 14.5 mm, 14 mm, 11.50 mm, and 16 mm for E. coli , S. typhimurium , B. subtilis , and S. aureus | Dowara et al. (2024) |
| Leaves essential oil | essential oil | Disc plate and agar well diffusion | Klebsiella sp., Pseudomonas aeruginosa , and Fusarium oxysporum | 18.5, 11.5, and 23 μg/mL for Klebsiella sp., Pseudomonas aeruginosa , and Fusarium oxysporum | Sidhu et al. (2023) |
| Leaves | Silver nanoparticles | Agar well diffusion | Aeromonas hydrophilia | 11 mm | Vijayaraj and Kumaran (2017) |
| Leaves | Ethanol | Agar well diffusion | E. coli and Staphylococcus aureus | 2.5 and 5 mg for E. coli and S. aureus | Ghadigaonkar (2023) |
| Flowers | Aqueous | Well diffusion | Streptococcus sanguinis | 6.35 mm | Farasayu et al. (2021) |
| Leaves | Water | Disc diffusion and micro‐dilution | Limosilactobacillus fermentum MA‐7 | 6.85 mm to 10.74 mm | Sağlam et al. (2023) |
| Stem bark | Methanol | Agar well diffusion | Staphylococcus aureus and Escherichia coli | 50 and 200 mg/mL for S. aureus and E. coli | Umar et al. (2024) |
| Flower | Water and methanol | Agar disc diffusion | Bacillus cereus , Staphylococcus aureus , Salmonella typhimurium , E. coli , and K. pneumonia | 11 mm, 15 mm, 9 mm, 14 mm, and 12.5 for the respective microbes | Rassem et al. (2024) |
| Seeds | Oil | Agar well diffusion | K. pneumonia | 6 mm at 10 μg/mL, 16 mm at 25 μg/mL, and 25 mm at 50 μg/mL | Yang et al. (2020) |
| Leaves | CoFe2O4 nanoparticles | Disc diffusion | S. aureus , B. Subtillis, and E. coli | 15, 20, and 7 μg/mL at 100 mm concentration for the respective strains | Singaravelan et al. (2024) |
| Leaves | Ethanol | Disc diffusion | Candida albicans , Candida tropicalis , and Candida glabrata | 9 mm, 8 mm, and 9 mm respectively | Zuhaira et al. (2020) |
| Flowers | Chloroform | Agar well diffusion | Candida albicans | 26.6 mm | Mohana et al. (2024) |
| Flowers | Aqueous | Diffusion | Staphylococcus aureus , Bacillus Subtilis , Pseudomonas Aeruginosa , and Escherichia coli | 17, 17, 16, and 18 mm for the selected strains at 100 μg/mL | Magalakshmi et al. (2022) |
| Flowers | Ethanol | Disc diffusion | Taphylococcus epidermidis and Staphylococcus saprophyticus | — | Patrice et al. (2017) |
9.6. Hepatoprotective Potential
The liver performs various functions, including detoxification of toxins, drugs, and other deleterious metabolites; metabolism of nutrients; digestion and absorption by producing bile; storage of glucose, vitamins, and minerals; and hormone regulation in the body to modulate the homeostatic environment (Rakhi et al. 2022). Medicinal plants such as H. rosa‐sinensis are investigated for improving liver health, whose evidence is described comprehensively here. Kumar (2020) examined the hepatoprotective effect of ethanolic and aqueous flower extract of H. rosa‐sinensis in carbon tetrachloride (CCl4) induced liver injury in rats. It has been shown that alanine transaminase (ALT), alkaline phosphatase (ALP), aspartate transaminase (AST), triglycerides (TG), bilirubin, and cholesterol levels were significantly alleviated by the administration of ethanol (200 mg/kg) and aqueous (400 mg/kg) flower extract of hibiscus. The comparative study determined the role of aqueous leaf extract of H. rosa‐sinensis and aqueous peel extract of pomegranates against liver disorders and CCl4‐induced oxidative stress in male albino rats. It has been shown that the supplementation of aqueous extract of H. rosa‐sinensis leaf (250, 500, and 750 mg/kg body weight) and pomegranate peel (100, 200, and 300 mg/kg body weight) has a similar influence in the alleviation of liver functional parameters. ALT levels were reduced from 29.55 to 20.15 U/L, AST from 47.97 to 30.99 U/L, ALP from 305.96 to 170.55 U/L, and total bilirubin from 3.11 mg/dL to 2.21 mg/dL (El‐Sayed 2018).
Similarly, Sattar Ali (2022) evaluated the hepatic protective effect of H. rosa‐sinensis zinc oxide nanoparticles and hibiscus extract on liver tissue and DNA fragmentation in adult male Wister rats (n = 35). The results showed that the subcutaneous administration of zinc oxide nanoparticles (75 and 100 mg/kg body weight) has comparatively increased AST, ALP, and ALT activity compared to zinc oxide nanoparticles at a 25 mg/kg body weight concentration. However, hibiscus extract has a limited attenuating impact on AST, ALP, and ALT. Previously, Biswas et al. (2014) explored the hypocholesterolemic potential of aqueous flower extract of H. rosa‐sinensis in diet‐induced hypercholesterolemia in 180–230 g male Wister rats (n = 42). It has been observed that body weight, AST, ALT, ALP, total protein, and MDA levels were reduced by consuming 240 mg/kg of body weight per day for a month. Lu et al. (2022) also synthesized silver nanoparticles from H. rosa‐sinensis and checked their impact on managing hepatic carcinoma. Silver nanoparticles showed dose‐dependent cytotoxic activity against hepatocellular cancer (SNU‐387), Morris hepatoma (McA‐RH7777), hepatic ductal carcinoma (LMH/2A), and Novikoff hepatoma (N1‐S1 Fudr).
Furthermore, Nwibo et al. (2016) evaluated the potential of H. rosa‐sinensis leaf extract on hyperlipidemic rats' liver and blood indices. They concluded that the leaf extract had not influenced the hematological parameters (hemoglobin, packed cell volume, and red blood counts). However, total cholesterol and LDL levels were significantly attenuated, and the hibiscus leaf extract improved HDL levels. In another study, Sahu (2016) determined the protective effect of H. rosa‐sinensis alcoholic leaf extract against piroxicam‐induced liver toxicity in adult Swiss albino mice (n = 60) by administering 30 mg/kg alcoholic leaf extract for 2 weeks. The outcomes demonstrated that the leaf extract of H. rosa‐sinensis decreased elevated ALT, AST, ALP, and hepatic lipid peroxidation levels. Similarly, Hussain et al. (2017) revealed that the cadmium‐induced hepatic toxicity in adult male albino rabbits was significantly ameliorated by the flavonoid‐enriched H. rosa‐sinensis leaves and flowers (200 mg/kg/day for 2 months), thereby demonstrating the hepatoprotective potential. Previously, Gomathi et al. (2008) exposed that the flower petals of H. rosa‐sinensis lowered the levels of monosodium glutamate, which triggered elevation of free fatty acids, TG, TC (total cholesterol), LDL, and VLDL (very low‐density lipoprotein). Similar results were observed in triton and atherogenic diet‐induced hyperlipidemic rats by the oral supplementation of 500 mg/kg body weight ethanolic flower extract of H. rosa‐sinensis (Sikarwar Mukesh and Patil 2011).
Recently, Dayal et al. (2022) used an aqueous extract of H. rosa‐sinensis and Butea monosperma in their hepatoprotective investigation against ferric nitrilotriacetate‐induced toxicity in rats. Liver functional biomarkers (ALT, AST, and ALP), triglycerides, lipids, proteins, and oxidative markers were alleviated by both extracts. In another investigation, Han et al. (2020) described that the methanolic extract of H. rosa‐sinensis improved aminopyrine metabolism by elevating hepatic CYP3A4 activity. In a similar year, Adil and Manampiring (2020) inquired about the potential of 1 mL polar (0.075 g mg/200 g BB/day in 0.5% CMC suspension) and non‐polar flowers extract of hibiscus (0.075 mg/200 g BB/day in 1% CMC suspension) on paracetamol‐stimulated hepatic toxicity in male white rats for 8 days. It has been observed that polar and non‐polar hibiscus extracts maintain the levels of SGOT and SGPT. Similarly, Rajavelu and Bs (2024) showed that the ethanolic leaf extract of H. rosa‐sinensis ameliorated liver cancer by inducing apoptosis through modulating BAX and BCL‐2. The hepatoprotective activity of H. rosa‐sinensis is shown in Figure 4.
FIGURE 4.

Hepatoprotective mechanism of Hibiscus rosa‐sinensis via reducing liver enzymes, alleviating oxidative stress, modulating CYP3A4 activity, regulating BCL‐2 and BAX expression, and lowering LDL, VLDL, TGs.
9.7. Antidepressants and Neuroprotective Activity
Anxiety and neurodegenerative disorders are reducing the healthy and normal life expectancy of individuals. Oxidative stress and inflammation are provoked by several factors, such as processed and fried food consumption, prolonged and repeated infections, aging, neuroinflammation, and heavy metals exposure, which induce neurodegenerative disorders (Castillo‐Rangel et al. 2023; Angelopoulou et al. 2022; Dolgacheva et al. 2022). The effect of H. rosa‐sinensis in mitigating neurological symptoms and its associated disorders has been reported. Shewale et al. (2012) proposed a study to evaluate the antidepressant capability of methanolic flower extract of flavonoid (anthocyanins) enriched H. rosa‐sinensis (30 and 100 mg/kg) by tail suspension and forced swim test. It has been observed that the duration of Haloperidol, Prazosin, and p‐chlorophenyl alanine‐stimulated immobility was decreased in both tests, confirming antidepressant activity. Similarly, Khalid et al. (2014) inquired about the antidepressant activity of ethanol flower extract of H. rosa‐sinensis at 100, 250, and 500 mg/kg doses by conducting forced‐induced swimming, tail suspension, and open field tests. The results revealed that all the supplemented dosages reduced immobility duration in forced‐induced swimming and tail suspension tests, while no significant effect was observed in open field tests.
Moreover, Sheikhar et al. (2024) assessed the antidepressant potential of H. rosa‐sinensis leaves in Swiss albino mice of 20 to 35 g by administering 200 and 400 mg/kg extract for 2 weeks and concluded that the ethanolic extract (400 mg/kg) of H. rosa‐sinensis leaves has antidepressant potential. Sucharitha and Nagamani (2021) conducted a forced swimming test, tail suspension test, and sleep‐induced test to determine the anxiolytic role of ethyl acetate flower and hibiscus leaf extract. The immobility time was attenuated dose‐dependently in all the selected tests with the oral intake of 100 and 200 mg/kg extract dose, demonstrating anxiolytic effects through adrenergic, dopaminergic, and serotonergic mechanisms. The antidepressant effect of ethanolic hibiscus extract (500 mg/kg) was revealed in mice by suppressing ionotropic GABA receptors (Begum and Younus 2018). In another study, Vijayanand et al. (2018) prepared solid lipid nanoparticles from H. rosa‐sinensis . They evaluated their antidepressant activity in male Swiss albino mice and found that solid lipid nanoparticles ameliorated immobility time more than their crude extract.
The neuroprotective capability of methanolic extract of H. rosa‐sinensis against the bilateral common carotid artery (BCCA) occlusion model of global cerebral ischemic‐reperfusion was evaluated by supplementing 100, 200, and 300 mg/kg/day for six consecutive days. The outcomes revealed that SOD, CAT, and GSH activity was reduced by hibiscus extract, ultimately reducing anxiety as well as modulating learning and memory (Nade et al. 2010). Previously, Nade et al. (2009) demonstrated that the methanolic roots extract of H. rosa‐sinensis (100 to 300 mg/kg) lowered lipid peroxidation and upregulated SOD, CAT, and GSH levels in reserpine‐induced neurobehavioral modifications in the brain. Recently, Shen et al. (2021) showed that the Quercetin 3‐O‐sophoroside isolated from H. rosa‐sinensis improved learning and memory in Alzheimer‐affected mice. Moreover, neuronal impairment in the hippocampal CA1 region and SCOP‐induced reduction in ChAT and ACh expression and AChE expression were improved and reversed by Quercetin 3‐O‐sophoroside.
10. Miscellaneous Properties
H. rosa‐sinensis has several other health‐promoting properties besides its antioxidant, antimutagenic, anti‐inflammatory, antimicrobial, cardioprotective, and neuroprotective characteristics. Soni and Gupta (2011) assessed the aqueous root extract of H. rosa‐sinensis as an antipyretic agent against yeast‐provoked pyrexia in Swiss albino rats using the flicking method. The results showed that the intake of 250 mg/kg body weight aqueous root extract has a dose‐dependent effect in attenuating pyrexia. Previously, Sawarkar et al. (2009) revealed the temperature‐lowering potential of aqueous (100 mg/kg) and alcoholic (200 mg/kg) extract of H. rosa‐sinensis in pyretic Wister rats. Moreover, Daud et al. (2016) demonstrated the antipyretic property of aqueous extract (500 mg/kg body weight) of H. rosa‐sinensis . Similarly, Aziz et al. (2021) inquired about the underlying temperature ameliorating potential of the ethanolic extract of white and red colored H. rosa‐sinensis . It has been noticed that the administration of 5 and 50 mg/kg white flower extract significantly alleviated the total temperature in rats.
Vasudeva and Sharma (2008) described that the ethanolic root extract of H. rosa‐sinensis at the concentration of 400 mg/kg body weight has potent anti‐implantation and uterotropic activity. Similarly, Jana et al. (2013) demonstrated that the crude flower extract of H. rosa‐sinensis at 300 mg/kg for 30, 45, and 60 days resulted in the deteriorating germinal epithelium of testes, consequently revealing antifertility in male albino rats (n = 84). Additionally, Kareem et al. (2022) and AL‐Azawi and Al‐hady (2020) demonstrated that the nanoparticles of H. rosa‐sinensis and the flower extract of H. rosa‐sinensis reduced fertility in male albino rats. Furthermore, Gupta and Yadav et al. (2024) investigated the potential of oral supplementation of H. rosa‐sinensis aqueous, ethanol, and benzene leaf extract (100 mg/kg body weight per day for 35 days) on the reproductive health of male albino rats. It has been shown that the benzene extract modified the testis, seminal vesicle, and epididymis and ameliorated spermatogenesis and fertility.
The petroleum ether leaves and flower extract of H. rosa‐sinensis were employed by Rose et al. (2020) to evaluate their effect on the hair growth of Dawley Sprague rats for 7 weeks. It has been noticed that the leaf extract has comparatively excessive hair growth compared to the flower extract of H. rosa‐sinensis . Later, Lailiyah (2023) used ethanol leaf extract of H. rosa‐sinensis in his study to prepare the cream for hair growth and investigated its impact on the hair growth of white rabbits and concluded that the cream at 20% concentration produced more hairs than at other concentrations, i.e., 10% and 15%. In a recent investigation, Khadasare et al. (2024) formulated a serum by combining hibiscus flowers and leaves, olive oil, peppermint oil, amla powder, vitamin E, curry leaves, lavender oil, and coconut oil, which promoted hair growth, hair quality, and strengthened them. Similarly, Parihar et al. (2024) revealed that the formulations made by H. rosa‐sinensis flowers, Allium cepa bulbs, Eclipta alba leaves, and Trigonella foenum‐graecum seeds improved hair growth as well as ameliorated hair fall.
11. Synergistic Role With Other Plants
The potency and effectiveness of plants and compounds are significant challenges directly or indirectly influenced by various factors, such as genetics, bioavailability, administration route, dose, and formulations. Recent debates have continued developing novel alternative strategies for improving the efficiency of plants. Multiple studies have been conducted on evaluating the synergetic significance of plants and compounds, and it has been observed that the plants/compounds supplemented in combination have comparatively better outcomes than plants/compounds supplemented alone. For instance, the antimicrobial potential of H. rosa sinensis leaves oil and its metabolite, dioctyl phthalate, was evaluated synergistically against Klebsiella species, Pseudomonas aeruginosa , and Fusarium oxysporum using disc plate and agar well diffusion method. The results revealed higher antimicrobial activity by exhibiting MICs of 18.5, 11.5, and 23 μg/mL against the respective bacterial and fungal strains (Sidhu et al. 2023).
Moreover, diabetes mellitus is prevailing throughout the world, which affects other organs of the body, particularly reproductive health among males. Chauhan and Rani (2024b) investigated the combination effect of H. rosa sinensis and camel milk on reproductive health in diabetic Wistar rats for 4 weeks. The results showed that pancreatic and seminiferous tubule damage caused by diabetes was significantly alleviated by the synergistic provision of camel milk and H. rosa sinensis. Furthermore, the supplementation has improved sperm motility, count, and viability, thereby modulating the reproductive health of males. Another study described that the blend prepared by H. rosa sinensis flower and Maranta arundinacea L. was used as a rice substitute owing to its low bulk density (0.83 g/mL) and starch digestibility (0.62 g/mL) as compared to rice (Antari et al. 2024). Diseases caused by oxidative stress are increasing globally, which can be managed by consuming antioxidant‐enriched products. Tea consumption is prevailing worldwide due to its soothing and relaxing properties. Herbal tea is formulated by combining green tea with Ocimum gratissimum , Cymbopogon citratus , Cymbopogon flexuosus , and H. rosa sinensis, and its antioxidant potential was evaluated by conducting DPPH and ABTS. The results depicted strong DPPH and ABTS scavenging activity by showing the respective EC50 values of 38.8 and 5.43 μg/mL, 53.6 and 11.6 μg/mL, 155.4 and 57.5 μg/mL, 295.3 and 49.1 μg/mL by H. rosa sinensis, O. gratissimum , C. flexuosus , and C. citratus , thereby could be used as a chemotherapeutic agent (Farooq and Sehgal 2019). Table 4 highlights the synergic role of H. sinensis with other medicinal plants.
TABLE 4.
Synergistic studies of Hibiscus rosa Sinensis with other plants.
| Disease | Plants | Supplementation and specimen | Outcomes | References |
|---|---|---|---|---|
| Diabetes mellitus | Matricaria Chamomilla | Peach drinks enriched with H. rosa sinensis and Matricaria Chamomilla , and rats | ↑serum insulin, ↑HDL levels, ↓fasting blood glucose, ↓random blood glucose, ↓LDL, ↓TC, ↓TG | Yasin et al. (2025) |
| Antibacterial activity | Chrysanthemum indicum , and Calendula officinalis flower | Gram‐positive ( Bacillus cereus MTCC 430, Staphylococcus aureus MTCC 87, Listeria monocytogenes MTCC 657, Clostridium perfringens MTCC 450) and gram‐negative ( Escherichia coli MTCC 43, Salmonella typhi MTCC 1264, and Pseudomonas aeruginosa MTCC424) strains | MIC = 3.75%–7.5%, and MBC (minimum bactericidal concentration) = 1.9%–3.8% | Karnwal (2022) |
| Hepatic CYP3A4 activity | Brassica oleracea and Tradescantia zebrina | Rat liver microsomes | ↑CYP3A4 activity, interact with aminopyrine metabolism | Han et al. (2020) |
| Anti‐inflammatory potential | Hibiscus sabdariffa | Endothelial cells (HUVECs) as a model for RAGE‐mediated inflammation screening | ↓inflammation, ↓TNF‐α, ↓IL‐6, and ↓VCAM‐1 | Lima (2022) |
| Wound healing activity | Curcuma longa rhizomes | Ointment prepared from H. rosa sinensis and Curcuma longa rhizome extracts, applied daily on Sprague Dawley rats for 20 days | ↑wound contraction (93%) | Mustaffa et al. (2020) |
| Centella asiatica | Combination application of Centella asiatica and H. rosa sinensis extract on 24 rats | ↑wound healing, ↑COL53A, ↑CXCL11, ↑CSF2, ↑IL6ST, ↑CXCL5, ↑ITGA5, ↑PLAT, and ↑WISP1 | Zulkurnain et al. (2025) | |
| Body scrubber | Citrofortunella macrocarpa and Psidium guajava | Citrofortunella macrocarpa, Psidium guajava , and H. rosa sinensis extract prepared with sea salt, coconut oil, honey, and powdered milk | ↓dry skin, ↓dead skin cells | Alfante et al. (2019) |
| Stress‐induced alopecia | Baccaurea Racemosa | H. rosa‐sinensis L. and B. racemosa extracts in male Wistar albino rats | ↑hair length, ↑hair density, and ↑hair follicles | Indrayoni and Padmiswari (2022) |
12. Molecular Docking
Molecular docking predicts how two molecules, such as a ligand and a protein, bind together by exploring conformations. It uses computational algorithms to estimate binding affinities, guiding drug design and virtual screening. Docking accelerates the identification of potential therapeutics by modeling intermolecular interactions and optimizing complementarity and structural precision. The current section contains molecular docking of various bioactive compounds of H. sinensis , like rutin, quercetin, and myricetin, against different proteins such as α‐glucosidase and superoxide dismutase (SOD) to evaluate the antidiabetic and hepatoprotective role of H. sinensis . The ligands, i.e., rutin (CID 5280805), quercetin (CID: 5280343), and myricetin (CID: 5281672), were accessed in 3D SDF format through the PubChem database. While, proteins, i.e., α‐glucosidase and SOD, were retrieved from Protein Data Bank (PDB) with the following PDB IDs 5DKZ (2.40 Å) and 1P7G (1.80 Å), in PDB format, respectively. Moreover, PyRx (AutoDock Vina) and Discovery Studio software were used to analyze binding affinity and visualize structures. The following grid box dimensions (X: 1.6825, Y: 129.1842, Z: 139,9902) for rutin (X: 0.0352, Y: 132.1277, Z: 159.8043) for quercetin, and (X: 122.2965, Y: 102.3505, Z: 25.0000) for myricetin and exhaustiveness (Akhtar et al. 2022) were observed during the docking of 5DKZ. While the 1P7G protein exhibited X: 190.4571, Y: 328.5863, Z: 19.0058 for rutin, X: 162.9047, Y: 329.2597, Z: 25.0000 for quercetin, and X: 141.6282, Y: 337.9629, Z: 25.0000 for myricetin, with exhaustiveness: 8.
The docking of ligands with proteins and their binding affinity is displayed in Figures 5, 6, 7, 8, 9, 10, as well as Tables 5 and 6.
FIGURE 5.

Rutin and α‐glucosidase interaction, (a) 2‐D structure, (b) 3‐D interaction, and (c) hydrogen bond surface.
FIGURE 6.

Quercetin and α‐glucosidase interaction, (a) 2‐D structure, (b) 3‐D interaction, and (c) hydrogen bond surface.
FIGURE 7.

Myricetin and α‐glucosidase interaction, (a) 2‐D structure, (b) 3‐D interaction, and (c) hydrogen bond surface.
FIGURE 8.

Rutin and SOD interaction, (a) 2‐D structure, (b) 3‐D interaction, and (c) hydrogen bond surface.
FIGURE 9.

Quercetin and SOD interaction, (a) 2‐D structure, (b) 3‐D interaction, and (c) hydrogen bond surface.
FIGURE 10.

Myricetin and SOD interaction, (a) 2‐D structure, (b) 3‐D interaction, and (c) hydrogen bond surface.
TABLE 5.
Residues with types of interaction and distance along with binding affinity of investigated molecules.
| Protein | Compound | Amino acids | Distance (Å) | Category | Types | Energy (Kcal/mol) |
|---|---|---|---|---|---|---|
| α‐glucosidase | Rutin | ASP303 | 2.19926 | Hydrogen Bond | Conventional Hydrogen Bond | −8.2 |
| HIS34 | 2.10947 | Hydrogen Bond | Conventional Hydrogen Bond | |||
| TRP517 | 2.53231 | Hydrogen Bond | Conventional Hydrogen Bond | |||
| ASP633 | 3.76315 | Electrostatic | Pi‐Anion | |||
| PHE305 | 5.74975 | Hydrophobic | Pi‐Pi Stacked | |||
| TRP515 | 4.96748 | Hydrophobic | Pi‐Alkyl | |||
| Quercetin | HIS34 | 2.1427 | Hydrogen Bond | Conventional Hydrogen Bond | ||
| HIS693 | 3.68684 | Hydrogen Bond | Carbon Hydrogen Bond | −8 | ||
| ASP633 | 3.86745 | Electrostatic | Pi‐Anion | |||
| MET557 | 5.33197 | Other | Pi‐Sulfur | |||
| PHE563 | 4.02503 | Hydrophobic | Pi‐Pi Stacked | |||
| TRP517 | 5.27173 | Hydrophobic | Pi‐Pi T‐shaped | |||
| Myricetin | HIS693 | 3.65464 | Hydrogen Bond | Carbon Hydrogen Bond | −8.6 | |
| ASP633 | 4.39916 | Electrostatic | Pi‐Anion | |||
| PHE305 | 5.43286 | Hydrophobic | Pi‐Pi Stacked | |||
| TRP415 | 5.67302 | Hydrophobic | Pi‐Pi Stacked | |||
| PHE666 | 4.8258 | Hydrophobic | Pi‐Pi Stacked |
TABLE 6.
Residues with types of interaction and distance along with binding affinity of investigated molecules.
| Protein | Compound | Amino acids | Distance (Å) | Category | Types | Energy (Kcal/mol) |
|---|---|---|---|---|---|---|
| SOD | Rutin | HIS46 | 2.29024 | Hydrogen Bond | Conventional Hydrogen Bond | −10.5 |
| ARG74 | 1.92328 | Hydrogen Bond | Conventional Hydrogen Bond | |||
| ARG190 | 2.29096 | Hydrogen Bond | Conventional Hydrogen Bond | |||
| GLU179 | 2.25398 | Hydrogen Bond | Conventional Hydrogen Bond | |||
| Quercetin | ARG74 | 2.20032 | Hydrogen Bond | Conventional Hydrogen Bond | −8.4 | |
| ARG190 | 4.05366 | Electrostatic | Pi‐Cation | |||
| GLU137 | 3.29044 | Hydrogen Bond | Carbon Hydrogen Bond | |||
| GLU179 | 2.19554 | Hydrogen Bond | Conventional Hydrogen Bond | |||
| Myricetin | ARG190 | 4.25339 | Electrostatic | Pi‐Cation | −8.3 | |
| HIS83 | 4.81584 | Hydrophobic | Pi‐Pi T‐shaped | |||
| GLU137 | 3.66604 | Hydrogen Bond | Carbon Hydrogen Bond | |||
| ARG74 | 2.40734 | Hydrogen Bond | Conventional Hydrogen Bond | |||
| TRY182 | 2.44405 | Hydrogen Bond | Conventional Hydrogen Bond |
13. Safety and Toxicity
The safety of plants and compounds is a fundamental consideration in the healthcare and food industries before their implementation in markets. Excessive and long‐term consumption of compounds poses several adverse health consequences in the form of carcinogens, cognitive impairment, hepatotoxicity, renal failure, and dermatological and gastrointestinal disorders. Limited investigations regarding the safety of plants and their derived compounds are conducted, which provide limitations in their implementations. Regarding the safety of H. rosa‐sinensis , it is safe to use and even effective in curing various prevailing health disorders among individuals. Meena et al. (2014) investigated the acute toxicity of the methanolic flower extract of H. rosa‐sinensis in Balb/c mice by providing different doses, i.e., 100, 200, 400, 800, and 1600 mg/kg body weight of extract through oral gavage. It has been observed that the methanolic flower extract did not produce any adverse effects in the form of behavior abnormality, respiratory symptoms, reduced food and water consumption, and hair loss up to 800 mg/kg body weight. However, ~20% mortality cases were observed in Balb/c mice consuming 1600 mg/kg H. rosa‐sinensis extract.
Furthermore, Valdivié and Martínez (2022) and Nath and Yadav (2014) revealed the toxicity of the methanolic leaves extract of H. rosa‐sinensis in mice, which were supplemented with an 800 mg/kg body weight dose for 2 weeks. The elevated ALT, ALP, AST, urea, creatinine, and bilirubin levels were observed at the 800 mg/kg body weight dose. However, the extract's safe and lethal dose (LD50) was recorded up to the doses of 400 and 2000 mg/kg body weight, respectively. Recently, a study on albino rats revealed that the LD50 for the methanolic extract of the stem bark of H. sinensis was 5000 mg/kg, showing its acceptance and tolerability at such a high dose (Umar et al. 2024). Considering all this, it has been verified that H. sinensis could be safe up to 400 mg/kg body weight for 14 days; however, 800 mg/kg for 14 days might cause hepato‐renal adverse effects. Moreover, the LD50 for the leaves extract is 2000 mg/kg, while for the stem extract it is 5000 mg/kg.
14. Industrial Applications
Industries have been utilizing natural resources for the last few years to develop sustainable and eco‐friendly environmental products that are cost‐effective and healthy for consumers. Medicinal plants have gained importance in various pharmaceutical, nutraceutical, cosmetic, food and beverage industries. H. rosa‐sinensis has found its applications in various sectors due to the presence of unique bioactive compounds. A study by Khan et al. (2017) and Baranova et al. (2012) reported that H. rosa‐sinensis has been employed as a flavoring agent in preparing jams, soups, and spices. Another study by Pieracci et al. (2021) employed H. rosa‐sinensis flowers in the beer industry. They evaluated its aroma and sensory properties, which revealed the floral and fruity notes enriched with esters and alcohol in Hibiscus beer. At the same time, the control beer had malty and hoppy notes. Additionally, the red color of H. rosa‐sinensis is fundamental owing to the presence of anthocyanins, which are used as coloring agents in food industries along with cyanidin‐3‐O‐glucoside and delphinidin (Mejía et al. 2023; Sinha and Asimi 2007).
The antioxidant, anticancer, hypoglycemic, hepatoprotective, hypotensive, and anti‐depressive attributes of H. rosa‐sinensis enable it to synthesize drugs and supplements in the nutraceutical and pharmaceutical industries. The polymers of gums and mucilage are prepared for H. rosa‐sinensis , which are employed in drug preparation and enhance their bioavailability (Yahaya et al. 2023; Weerasingha et al. 2021). Anthocyanins are extracted in abundance by preparing a methanolic solution of 4% citric acid, which is then used as a natural dye by maintaining a standard pH of 4. However, cotton and silk dyes' rapid properties were achieved with stannous mordanted fabrics (Vankar and Shukla 2011; Vankar and Srivastava 2008). The industrial applications of H. rosa‐sinensis are displayed in Figure 11.
FIGURE 11.

Industrial applications of H. rosa‐sinensis .
15. Conclusion and Future Perspectives
Due to versatile biomedical applications contributing significantly to health maintenance, there has been an increased demand for improving the endurance and subsistence of individuals through medicinal plants, as well as H. rosa‐sinensis . The bioactive compounds, such as quercetin, kaempferol, anthocyanins, saponins, alkaloids, and essential oils, enhance the therapeutic potential of H. rosa‐sinensis . These compounds reduce oxidative and oxidative stress‐induced disorders by attenuating free radicals and inflammatory markers. Various in vitro and in vivo studies have confirmed the antidiabetic, hypolipidemic, hypotensive, neuroprotective, and cardioprotective properties. Moreover, the anticancer activity of H. rosa‐sinensis via modulation of inflammatory markers (IL‐6, IL‐1β, TNF‐α) and genes like ESR1 and HER2 has also been reported. Studies have also reported the safety of H. rosa‐sinensis in nutraceuticals, supplements, and functional foods, with few adverse impacts. Its adaptogenic ability to diverse environments makes it an excellent choice for industrial applications. Its flowers and plant extracts are used as a coloring and flavoring agent in food industries and as a tonic to slow aging and promote hair growth. Despite its substantial pharmaceutical and nutraceutical applications there is a lack of clinical trials on safety and therapeutic potential, thus hindering its significance and future implications. Moreover, H. rosa‐sinensis contains diverse bioactive compounds like anthocyanins, which are sensitive and unstable towards light, temperature, pH, and even oxygen. Therefore, further clinical investigations are required to validate its efficacy, extraction methods, and industrial applications. In addition, the handling of this plant needs special attention and effective techniques to obtain its maximum bioactives yield. In the last, the synergistic interaction with other plants, compounds, standard drugs, and therapeutic approaches can enhance H. rosa‐sinensis pharmacological potential.
Author Contributions
Hassan Raza: writing – original draft. Muhammad Tauseef Sultan: supervision. Khalil Ahmad: supervision. Muhammad Maaz: writing – original draft. Shehnshah Zafar: writing – reviewing. Ahmad Mujtaba Noman: writing – review and editing. Entessar Mohammad Al Jbawi: writing – review and editing.
Funding
The authors have nothing to report.
Ethics Statement
The authors have nothing to report.
Consent
All authors are agreed to publish this work.
Conflicts of Interest
The authors declare no conflicts of interest.
Raza, H. , Sultan M. T., Ahmad K., et al. 2025. “ Hibiscus rosa‐sinensis : A Multifunctional Flower Bridging Nutrition, Medicine, and Molecular Therapeutics.” Food Science & Nutrition 13, no. 12: e71254. 10.1002/fsn3.71254.
Contributor Information
Hassan Raza, Email: sh.raza40@yahoo.com.
Muhammad Tauseef Sultan, Email: tauseefsultan@bzu.edu.pk.
Entessar Mohammad Al Jbawi, Email: dr.entessara@gmail.com.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
- Abate, T. A. , and Belay A. N.. 2022. “Assessment of Antibacterial and Antioxidant Activity of Aqueous Crude Flower, Leaf, and Bark Extracts of Ethiopian Hibiscus rosa‐sinensis Linn: Geographical Effects and Co2Res2/Glassy Carbon Electrode.” International Journal of Food Properties 25, no. 1: 1875–1889. [Google Scholar]
- Abd El‐Kader, M. F. H. , Elabbasy M. T., Adeboye A. T., Zeariya M. G., and Menazea A. A.. 2021. “Morphological, Structural and Antibacterial Behavior of Eco‐Friendly of ZnO/TiO2 Nanocomposite Synthesized via Hibiscus rosa‐sinensis Extract.” Journal of Materials Research and Technology 15: 2213–2220. [Google Scholar]
- Adil, E. H. , and Manampiring N.. 2020. “Hepatoprotective Activities of Polar and Non‐ Polar Extract Kembang Sepatu Flower (Hibiscus Rosasinensis L.).” Indonesian Biodiversity 1: 50–59. [Google Scholar]
- Afiune, L. A. F. , Leal‐Silva T., Sinzato Y. K., et al. 2017. “Beneficial Effects of Hibiscus rosa‐sinensis L. Flower Aqueous Extract in Pregnant Rats With Diabetes.” PLoS One 12: e0179785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Agarwal, S. , and Prakash R.. 2013. “Essential Oil Composition of Solvent Extract of Hibiscus Rosasinensis Flower.” Oriental Journal of Chemistry 29, no. 2: 813–814. [Google Scholar]
- Agrawal, K. K. , Murti Y., Agrawal N., and Gupta T.. 2021. “In Silico Studies of Bioactive Compounds From Hibiscus rosa‐sinensis Against HER2 and ESR1 for Breast Cancer Treatment.” International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN) 14, no. 6: 5665–5671. [Google Scholar]
- Ahmed, N. , Sheikh M. A., Ubaid M., Chauhan P., Kumar K., and Choudhary S.. 2024. “Comprehensive Exploration of Marine Algae Diversity, Bioactive Compounds, Health Benefits, Regulatory Issues, and Food and Drug Applications.” Measurement: Food 14: 100163. [Google Scholar]
- Akhtar, S. , Asiri S. M., Khan F. A., et al. 2022. “Formulation of Gold Nanoparticles With Hibiscus and Curcumin Extracts Induced Anti‐cancer Activity.” Arabian Journal of Chemistry 15, no. 2: 103594. [Google Scholar]
- Al‐Alak, S. K. , AL‐Oqaili R. M. S., Mohammed B. B., and Abd‐Alkhalik N.. 2015. “Antibacterial Activity of Hibiscus rosa‐sinensis Extract and Synergistic Effect With Amoxicillin Against Some Human Pathogens.” American Journal of Phytomedicine and Clinical Therapeutics 3: 20–27. [Google Scholar]
- AL‐Azawi, R. S. , and Al‐hady F. N.. 2020. “Testosterone and Progesterone Levels, Gene Expression of Androgen and Progesterone Receptors in Albino Male Rats Treated With Phenolic Flower Extract of Hibiscus Rosa‐sinensis L.” Medico‐Legal Update 20: 1. [Google Scholar]
- Alfante, K. C. A. , Suratos G. F., and Dayrit K. L.. 2019. “Synergistic Activity of Calamansi (Citrofortunella Microcarpa), Riped Guava ( Psidium guajava ) and Gumamela ( Hibiscus rosa‐sinensis ) Flower Extracts as Body Scrub.” Philippine Journal of Natural and Social Sciences 1: 1. [Google Scholar]
- Al‐Snafi, A. E. 2018. “Chemical Constituents, Pharmacological Effects and Therapeutic Importance of Hibiscus rosa‐sinensis‐A Review.” IOSR Journal of Pharmacy 8, no. 7: 101–119. [Google Scholar]
- Amtaghri, S. , Amssayef A., Slaoui M., and Eddouks M.. 2022. “Antihypertensive and Vasorelaxant Effects of Hibiscus rosa‐sinensis Through Angiotensin‐Converting Enzyme‐2 (ACE‐2), and Ca2+ Channels Pathways.” Cardiovascular & Haematological Disorders‐Drug Targets (Formerly Current Drug Targets‐Cardiovascular & Hematological Disorders) 22, no. 1: 27–37. [DOI] [PubMed] [Google Scholar]
- Amtaghri, S. , Qabouche A., Slaoui M., and Eddouks M.. 2024. “A Comprehensive Overview of Hibiscus rosa‐sinensis L.: Its Ethnobotanical Uses, Phytochemistry, Therapeutic Uses, Pharmacological Activities, and Toxicology.” Endocrine, Metabolic & Immune Disorders 24, no. 1: 86–115. [DOI] [PubMed] [Google Scholar]
- Angelopoulou, E. , Paudel Y. N., Papageorgiou S. G., and Piperi C.. 2022. “Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review.” Brain Sciences 12, no. 2: 175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ansari, P. , Azam S., Hannan J. M. A., Flatt P. R., and Wahab Y. H. A.. 2020. “Anti‐Hyperglycaemic Activity of H. rosa‐sinensis Leaves Is Partly Mediated by Inhibition of Carbohydrate Digestion and Absorption, and Enhancement of Insulin Secretion.” Journal of Ethnopharmacology 253: 112647. [DOI] [PubMed] [Google Scholar]
- Antari, A. L. , Saraswati I., Annisa E., and Fatma A. A.. 2024. “Formulation and Characterization of Analog Rice Using Arrowroot (Maranta arundinacea L.) and Hibiscus Flower (Hibiscus rosa Sinensis L.).” Pharmacy & Pharmaceutical Sciences Journal/Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia 11, no. 3: 386–394. [Google Scholar]
- Anuradha, C. T. , and Raji P.. 2019. “Effect of Annealing Temperature on Antibacterial, Antifungal and Structural Properties of Bio‐Synthesized Co3O4 Nanoparticles Using Hibiscus Rosa‐sinensis .” Materials Research Express 6, no. 9: 095063. [Google Scholar]
- Arullappan, S. , Zakaria Z., and Basri D. F.. 2009. “Preliminary Screening of Antibacterial Activity Using Crude Extracts of Hibiscus rosa Sinensis.” Tropical Life Sciences Research 20, no. 2: 109–118. [PMC free article] [PubMed] [Google Scholar]
- Aziz, M. A. , Raduan S. Z., Roslida A. H., Zakaria Z. A., Zuraini A., and Hakim M. N.. 2021. “Anti‐Pyretic Activity of Two Varieties of Hibiscus rosa Sinensis L.” Biomedical and Pharmacology Journal 14, no. 1: 61–74. [Google Scholar]
- Bala, R. , Kaur R., Kaur B., and Kaur P.. 2022. “ Hibiscus rosa Sinensis Linn.: A Phytochemical and Pharmacological Review.” International Journal of Health Sciences 6: 5165–5193. [Google Scholar]
- Baranova, V. S. , Rusina I. F., Guseva D. A., Prozorovskaya N. N., Ipatova O. M., and Kasaikina O. T.. 2012. “The Antiradical Activity of Plant Extracts and Healthful Preventive Combinations of These Exrtacts With the Phospholipid Complex.” Biomeditsinskaya Khimiya 58, no. 6: 712–726. [DOI] [PubMed] [Google Scholar]
- Begum, Z. , and Younus I.. 2018. “Hibiscus rosa Sinensis Mediate Anxiolytic Effect via Modulation of Ionotropic GABA‐A Receptors: Possible Mechanism of Action.” Metabolic Brain Disease 33: 823–827. [DOI] [PubMed] [Google Scholar]
- Begum, Z. , Younus I., and Khan H.. 2018. “Analgesic and Anti‐Inflammatory Activities of the Ethanol Extract of Hibiscus rosa Sinensis Linn (Roots).” Pakistan Journal of Pharmaceutical Sciences 31, no. 5: p1927. [PubMed] [Google Scholar]
- Bhaskar, A. , and Vidhya V. G.. 2012. “Hypoglycemic and Hypolipidemic Activity of Hibiscus rosa Sinensis Linn on Streptozotocin–Induced Diabetic Rats.” International Journal of Diabetes in Developing Countries 32: 214–218. [Google Scholar]
- Biswas, A. , D'Souza U. J., Bhat S., and Damodar D.. 2014. “The Hepatoprotective Effect of Hibiscus rosa Sinensis Flower Extract on Diet‐Induced Hypercholesterolemia in Male Albino Wister Rats.” International Journal of Pharma Medicine and Biological Sciences 4, no. 6: 1–10. [Google Scholar]
- Buarki, F. , AbuHassan H., Al Hannan F., and Henari F. Z.. 2022. “Green Synthesis of iron Oxide Nanoparticles Using Hibiscus rosa Sinensis Flowers and Their Antibacterial Activity.” Journal of Nanotechnology 2022, no. 1: 5474645. [Google Scholar]
- Castillo‐Rangel, C. , Marin G., Hernandez‐Contreras K. A., and Vichi‐Ramirez M. M.. 2023. “Neuroinflammation in Parkinson's Disease: From Gene to Clinic: A Systematic Review.” International Journal of Molecular Sciences 24, no. 6: 5792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chaachouay, N. , and Zidane L.. 2024. “Plant‐Derived Natural Products: A Source for Drug Discovery and Development.” Drugs and Drug Candidates 3, no. 1: 184–207. [Google Scholar]
- Chai, Y. T. 2020. Antioxidant and Antibacterial Activities of Hybrid, White and Orange Hibiscus (Hibiscus Rosa‐Sinensis). Tunku Abdul Rahman University College. [Google Scholar]
- Chauhan, K. , and Rani S.. 2024a. “Evaluation of Antidiabetic Potential of Hibiscus rosa Sinensis on Streptozotocin‐Induced Diabetes on Wistar Albino Rats.” Journal of Applied and Natural Science 16, no. 1: 245–250. [Google Scholar]
- Chauhan, K. , and Rani S.. 2024b. “Synergistic Effect of Camel Milk and Hibiscus rosa Sinensis on the Reproduction of Type II Diabetic Albino Wistar Rats.” Journal of Applied and Natural Science 16, no. 4: 1582. [Google Scholar]
- Chen, Z. , Ding W., Yang X., Lu T., and Liu Y.. 2024. “Isoliquiritigenin, a Potential Therapeutic Agent for Treatment of Inflammation‐Associated Diseases.” Journal of Ethnopharmacology 318: 117059. [DOI] [PubMed] [Google Scholar]
- Daud, D. , Arsad N. F. M., Ismail A., and Tawang A.. 2016. “Anti‐Pyretic Action of Caulerpa lentillifera, Hibiscus rosa‐Sinensis and Piper Sarmentosum Aqueous Extract in Mice.” Asian Journal of Pharmaceutical and Clinical Research 9, no. 1: 9–11. [Google Scholar]
- Dayal, R. , Kumar B., Melkani I., et al. 2022. “Hepatoprotective Potential of Aqueous Extract of Hibiscus Rosasinensis and Butea monosperma Against Fe‐NTA Induced Hepatotoxicity in Rats.” Research Journal of Pharmacy and Technology 15, no. 7: 3213–3220. [Google Scholar]
- De Boer, H. J. , and Cotingting C.. 2014. “Medicinal Plants for Women's Healthcare in Southeast Asia: A Meta‐Analysis of Their Traditional Use, Chemical Constituents, and Pharmacology.” Journal of Ethnopharmacology 151, no. 2: 747–767. [DOI] [PubMed] [Google Scholar]
- Dolgacheva, L. P. , Zinchenko V. P., and Goncharov N. V.. 2022. “Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease.” International Journal of Molecular Sciences 23, no. 21: 13043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dowara, M. , Gogoi I., and Saikia S.. 2024. “Phytochemical Screening and In Vitro Antibacterial Activity of Hibiscus rosa‐sinensis L. Leaf Extracts.” Asian Journal of Biological and Life Sciences 13, no. 1: 35–39. [Google Scholar]
- Elemike, E. E. , Onwudiwe D. C., and Mbonu J. I.. 2021. “Facile Synthesis of Cellulose–ZnO‐Hybrid Nanocomposite Using Hibiscus rosa‐sinensis Leaf Extract and Their Antibacterial Activities.” Applied Nanoscience 11, no. 4: 1349–1358. [Google Scholar]
- El‐Sayed, M. S. S. 2018. “Effect of Hepatoprotective Role Evaluation of hibiscus rosa‐sinensis Leaves and Pomegranate (punica granatum) Peels Aq Ueous Extracts on Male Albino Rats.” Zagazig Journal of Agricultural Research 45, no. 1: 349–362. [Google Scholar]
- Eze, I. , and Nwibo D.. 2017. “Effects of Processing on Proximate Composition of Hibiscus rosa‐sinensis Leaf.” European Journal of Medicinal Plants 18, no. 2: 1–13. [Google Scholar]
- Falade, O. S. , Aderogba M. A., Kehinde O., Akinpelu B. A., Oyedapo B. O., and Adewusi S. R.. 2009. “Studies on the Chemical Constituents, Antioxidants and Membrane Stability Activities of Hibiscus rosa Sinensis .” Nigerian Journal of Natural Products Medicine 13: 58–64. [Google Scholar]
- Farasayu, R. D. , Rachmawati M. W., Ana I. D., Syaify A., and Listyarifah D.. 2021. “The Effect of Hibiscus Flower Extract ( Hibiscus rosa‐sinensis L.) on the Growth of Streptococcus sanguinis Bacteria.” In BIO Web of Conferences, vol. 41, p07006. EDP Sciences. [Google Scholar]
- Farooq, S. , and Sehgal A.. 2019. “Scrutinizing Antioxidant Interactions Between Green Tea and Some Medicinal Plants Commonly Used as Herbal Teas.” Journal of Food Biochemistry 43, no. 9: e12984. [DOI] [PubMed] [Google Scholar]
- Gauthaman, K. K. , Saleem M. T., Thanislas P. T., et al. 2006. “Cardioprotective Effect of the Hibiscus rosa Sinensis Flowers in an Oxidative Stress Model of Myocardial Ischemic Reperfusion Injury in Rat.” BMC Complementary and Alternative Medicine 6: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geeganage, J. R. , and Gunathilaka M. D. T. L.. 2024. “Mechanistic Insight Into Anti‐Inflammatory Potential of Hibiscus rosa‐sinensis Flower Extract as a Herbal Remedy: A Systematic Review.” Journal of Herbal Medicine 45: 100884. [Google Scholar]
- Ghadigaonkar, S. 2023. “Evaluation of Antibacterial Activity of Ethanolic and Aqueous Leaf Extract of Hibiscus rosa‐sinensis in Mice.” Group 4: 6. [Google Scholar]
- Ghaffar, F. R. A. , and El‐Elaimy I. A.. 2012. “In Vitro, Antioxidant and Scavenging Activities of Hibiscus rosa Sinensis Crude Extract.” Journal of Applied Pharmaceutical Science 2: 151–158. [Google Scholar]
- Goldberg, K. H. , Yin A. C., Mupparapu A., Retzbach E. P., Goldberg G. S., and Yang C. F.. 2016. “Components in Aqueous Hibiscus rosa‐sinensis Flower Extract Inhibit In Vitro Melanoma Cell Growth.” Journal of Traditional and Complementary Medicine 7, no. 1: 45–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gomathi, N. , Malarvili T., Mahesh R., and Begum V. H.. 2008. “Lipids Lowering Effect of Hibiscus rosa‐sinensis Flower Petals on Monosodium Glutamate (MSG) Induced Obese Rats.” Pharmacology 1: 400–409. [Google Scholar]
- Goyal, S. , Thirumal D., Singh S., et al. 2025. “Basics of Antioxidants and Their Importance.” In Antioxidants: Nature's Defense Against Disease, 1–20. Purdue University. [Google Scholar]
- Guddeti, V. , Babu D. M., Nagamani B., Teja M. R., Sravani M. S., and Spandana C. H.. 2015. “Evaluation of Anti Inflammatory Activity of hibiscus rosa Sinensis Linn. Flower Extract in Rats.” International Journal of Pharmaceutical, Chemical & Biological Sciences 5: p532. [Google Scholar]
- Gulati, K. 2022. “Evaluation of Cellular and Molecular Mechanisms of Therapeutic Effects of Hibiscus Rosa‐Sinensis and Piper nigrum in Experimental Model of Bronchial Asthma.” Medicon Pharmaceutical Sciences 2: 2–13. [Google Scholar]
- Gupta, A. , Jana G. K., Jangdey M. S., and Soni D.. 2014. “Exploration of Anti‐Inflammatory Activity of Aquaeous Extract of Hibiscus rosa Sinesis (Malvacae).” Research Journal of Pharmacognosy and Phytochemistry 6, no. 3: 109–111. [Google Scholar]
- Han, C. J. , Akowuah G. A., Shukkoor M. S. A., and Biswas A.. 2020. “Modulation of Rat Hepatic CYP3A4 Activity by Brassica oleracea, Hibiscus rosa Sinensis, and Tradescantia zebrina .” Biointerface Research in Applied Chemistry 11, no. 1: 7453–7459. [Google Scholar]
- Harini, V. S. 2024. “Evaluation of the Anticancer, Antidiabetic, and In Vitro Wound Healing Properties of the Aqueous and Ethanolic Extract of Hibiscus rosa‐sinensis L.” Journal of Pharmacy & Bioallied Sciences 16, no. 2: S1217–S1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hussain, N. , Chaudhary M. N., Anjum A. A., et al. 2017. “Amelioration of Hepato‐Renal Toxicity by a Flavonoid‐Rich Fraction of Hibiscus Rosa‐Sinenses (Leaves and Flowers) in Male Rabbits Intoxicated by Cadmium.” Polish Journal of Environmental Studies 26, no. 4: 1551–1563. [Google Scholar]
- Indrayoni, P. , and Padmiswari A. A. I. M.. 2022. “Potential of Hibiscus Rosa‐sinensis L. and Baccaurea Racemosa Extract as a Hair Growth With Tail Suspension Test Stress‐Induced Alopecia.” Ad‐Dawaa'journal of Pharmaceutical Sciences 5, no. 1: 28–33. [Google Scholar]
- Iqbal, A. , and Rehman M. Z. U.. 2023. “Determining Genetic Variability and Taxonomy of Hibiscus rosa‐sinensis Through rbcL Molecular Marker: Genetic Variability and Taxonomy of Hibiscus rosa‐sinensis .” Pakistan BioMedical Journal 6, no. 6: 29–36. [Google Scholar]
- Jana, T. K. , Das S., Ray A., Mandal D., Giri Jana S., and Bhattacharya J.. 2013. “Study of the Effects of Hibiscusrosa‐Sinensis Flower Extract on the Spermatogenesis of Male Albino Rats.” Journal of Physiology and Pharmacology Advances 3, no. 6: 167–171. [Google Scholar]
- Jeevan Kumar, G. J. , and Rajeshkumar S.. 2022. “Rose Hibiscus Black Currant Tea Extract Mediated Silver Nanoparticles and Its Anti‐Microbial, Anti‐Oxidant, Anti‐Inflammatory and Cytotoxic Effect.”
- Johariya, V. , Joshi A., Malviya N., and Malviya S.. 2024. “Introduction to Cancer.” In Medicinal Plants and Cancer Chemoprevention, 1–28. CRC Press. [Google Scholar]
- Kalpana, V. N. S. , Mary J., Mini S., Soumya N. P. P., and Mondal S.. 2021. “ Hibiscus rosa Sinensis L. Anthocyanins Prevent Lipid Peroxidation and Improve Antioxidant Status in the Liver of Streptozotocin‐Induced Diabetic Rats.” Bioactive Compounds in Health and Disease 4, no. 10: 240–255. [Google Scholar]
- Kandhare, A. D. , Raygude K. S., Ghosh P., et al. 2012. “Effect of Hydroalcoholic Extract of Hibiscus rosa Sinensis Linn. Leaves in Experimental Colitis in Rats.” Asian Pacific Journal of Tropical Biomedicine 2, no. 5: 337–344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kareem, S. H. , Alhady F. N. A., and Mansour A.. 2022. “Effect of Hibiscus Rosa Nanoparticles on Sperm Parameters of Male Albino Rats.” International Journal of Health Sciences 6, no. S6: 11017–11028. [Google Scholar]
- Karnwal, A. 2022. “In Vitro Antibacterial Activity of Hibiscus rosa Sinensis, Chrysanthemum Indicum, and Calendula officinalis Flower Extracts Against Gram Negative and Gram Positive Food Poisoning bacteria.” Advances in Traditional Medicine 22, no. 3: 607–619. [Google Scholar]
- Keservani, R. K. , Tung B. T., Kesharwani R. K., and Ahire E. D.. 2024. Plant Metabolites and Vegetables as Nutraceuticals. CRC Press. [Google Scholar]
- Khadasare, P. M. , Shinde S. A., Londe S. S., Inamdar S. A., and Kharat S. J.. 2024. “Formulation & Evaluation of Hair Growth Serum From Hibiscus Flowers and Leaves.” International Journal of Therapeutic Innovations 2, no. 5: 203–211. [Google Scholar]
- Khalid, L. , Rizwani G. H., Sultana V., Zahid H., Khursheed R., and Shareef H.. 2014. “Antidepressant Activity of Ethanolic Extract of Hibiscus rosa Sinenesis Linn.” Pakistan Journal of Pharmaceutical Sciences 27: 5. [PubMed] [Google Scholar]
- Khan, I. M. , Rahman R., Mushtaq A., and Rezgui M.. 2017. “ Hibiscus rosa‐sinensis L.(Malvaceae): Distribution, Chemistry and Uses.” International Journal of Chemical And Biochemical Sciences 12: 147–151. [Google Scholar]
- Khan, Z. A. , Naqvi S. A., Mukhtar A., et al. 2014. “Antioxidant and Antibacterial Activities of Hibiscus Rosa‐sinensis Linn Flower Extracts.” Pakistan Journal of Pharmaceutical Sciences 27, no. 3: 469–474. [PubMed] [Google Scholar]
- Khandelwal, V. K. M. , Balaraman R., Pancza D., and Ravingerová T.. 2011. “Hemidesmus Indicus and Hibiscus rosa‐sinensis Affect Ischemia Reperfusion Injury in Isolated Rat Hearts.” Evidence‐Based Complementary and Alternative Medicine 2011, no. 1: 802937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kumar, A. K. 2020. “Hepatoprotective Activity of Whole Flower of Hibiscus Rosa‐sinensis Linn Extracts in Wistar Rats.” Indian Drugs 57, no. 5: 65. [Google Scholar]
- Kumar Dwivedi, A. , and Jain A.. 2023. “Antioxidant and Antibacterial Activity of Leaves of Hibiscus rosa‐sinensis .” International Journal of Phytology Research 3, no. 4: 12–15. [Google Scholar]
- Kumar, V. , Mahdi F., Khanna A. K., et al. 2013. “Antidyslipidemic and Antioxidant Activities of Hibiscus rosa Sinensis Root Extract in Alloxan Induced Diabetic Rats.” Indian Journal of Clinical Biochemistry 28: 46–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lailiyah, M. 2023. “Hair Growth Cream Formulation From Shoe Flower Leaf Ethanol Extract ( Hibiscus rosa‐sinensis L.) as a Hair Grower in Rabbit ( Oryctolagus cuniculus ).” Jurnal Eduhealth 14, no. 02: 720–728. [Google Scholar]
- Lima, M. T. N. S. 2022. Evaluation of the Bioactivity of Hibiscus Extracts (Hibiscus Sabdariffa and H. rosa‐sinensis ) and Anti‐Inflammatory Potential.
- Lingesh, A. M. P. K. , Paul D., Naidu V. G. M., and Satheeshkumar N.. 2019. “AMPK Activating and Anti Adipogenic Potential of Hibiscus rosa Sinensis Flower in 3T3‐L1 Cells.” Journal of Ethnopharmacology 233: 123–130. [DOI] [PubMed] [Google Scholar]
- Lu, L. , Zhuang Z., Fan M., et al. 2022. “Green Formulation of ag Nanoparticles by Hibiscus rosa‐sinensis : Introducing a Novel Chemotherapeutic Drug for the Treatment of Liver Cancer.” Arabian Journal of Chemistry 15, no. 2: 103602. [Google Scholar]
- Magalakshmi, P. , Mandhurya A., Nandhini N., Abinaya C., and Savithri J. S.. 2022. “Antibacterial Activity and Qualitative Phytochemical Study of Hibiscus rosa Sinensis .” International Journal of Botany Studies 7, no. 3: 235–239. [Google Scholar]
- Magdalita, P. M. , and San Pascual A. O.. 2022. “Hibiscus ( Hibiscus rosa‐sinensis ): Importance and Classification.” In Floriculture and Ornamental Plants, 483–522. Springer Nature Singapore. [Google Scholar]
- Mahdy, A. K. , Lokes E., Schöpfel V., et al. 2024. “Bulk T Cell Repertoire Sequencing (TCR‐Seq) is a Powerful Technology for Understanding Inflammation‐Mediated Diseases.” Journal of Autoimmunity 149: 103337. [DOI] [PubMed] [Google Scholar]
- Mak, Y. W. , Chuah L. O., Ahmad R., and Bhat R.. 2013. “Antioxidant and Antibacterial Activities of Hibiscus ( Hibiscus rosa‐sinensis L.) and Cassia ( Senna bicapsularis L.) Flower Extracts.” Journal of King Saud University, Science 25, no. 4: 275–282. [Google Scholar]
- Mamun, A. , Islam S., Alam A. K., Rahman M. A. A., and Rashid M.. 2013. “Effects of Ethanolic Extract of Hibiscus rosa‐sinensis Leaves on Alloxan‐Induced Diabetes With Dyslipidemia in Rats.” Bangladesh Pharmaceutical Journal 16, no. 1: 27–31. [Google Scholar]
- Meena, A. K. , Jain A., Pandey K., and Singh R. K.. 2014. “Acute Toxicity and Genotoxic Activity of Hibiscus rosa‐sinensis Flower Extract.” American Journal of Phytomedicine and Clinical Therapeutics 2, no. 4: 524–529. [Google Scholar]
- Mejía, J. J. , Sierra L. J., Ceballos J. G., Martínez J. R., and Stashenko E. E.. 2023. “Color, Antioxidant Capacity and Flavonoid Composition in Hibiscus rosa‐sinensis Cultivars.” Molecules 28, no. 4: 1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mohan, M. , Shinde A., and Khade B.. 2011. “Effect of Anthocyanidin Fraction of Hibiscus Rosa‐sinensis on Blood Pressure in Deoxycorticosterone Acetate (DOCA)‐Salt‐Hypertensive Rats.” Pharmacology 3: 1097–1111. [Google Scholar]
- Mohana, P. , Singh A., Rashid F., et al. 2024. “Inhibition of Virulence Associated Traits by β‐Sitosterol Isolated From Hibiscus rosa‐sinensis Flowers Against Candida albicans: Mechanistic Insight and Molecular Docking Studies.” Journal of Microbiology 62: 1–11. [DOI] [PubMed] [Google Scholar]
- Moyo, H. N. 2024. “The Impact of Food Processing Techniques on Nutrient Retention and Bioavailability.” Iconic Research and Engineering Journals 8, no. 2: 435–460. [Google Scholar]
- Mustaffa, F. , Parasuraman S., and Sahgal G.. 2020. “Wound Healing Activity of Herbal Ointment Containing the Extracts of Hibiscus rosa‐sinensis Flowers and Curcuma longa Rhizomes.” Free Radicals and Antioxidants 10, no. 2: 86–88. [Google Scholar]
- Nade, V. S. , Dwivedi S., Kawale L. A., Upasani C. D., and Yadav A. V.. 2009. “Effect of Hibiscus rosa Sinensis on Reserpine‐Induced Neurobehavioral and Biochemical Alterations in Rats.” Indian Journal of Experimental Biology 47, no. 7: 559–563. [PubMed] [Google Scholar]
- Nade, V. S. , Kawale L. A., Dwivedi S., and Yadav A. V.. 2010. “Neuroprotective Effect of Hibiscus rosa Sinensis in an Oxidative Stress Model of Cerebral Post‐Ischemic Reperfusion Injury in Rats.” Pharmaceutical Biology 48, no. 7: 822–827. [DOI] [PubMed] [Google Scholar]
- Nagar, N. V. 2012. “Antimicrobial Evaluation of hibiscus rosa‐sinensis Plant Extracts Against Some Pathogenic Bacteria.” Bulletin of Environmental and Scientific Research 1, no. 3–4: 14–17. [Google Scholar]
- Nagarajappa, R. , Batra M., Sharda A. J., et al. 2015. “Antimicrobial Effect of Jasminum grandiflorum L. and Hibiscus rosa‐sinensis L. Extracts Against Pathogenic Oral Microorganisms‐An In Vitro Comparative Study.” Oral Health & Preventive Dentistry 13, no. 4: 341–348. [DOI] [PubMed] [Google Scholar]
- Nath, P. , and Yadav A. K.. 2014. “Acute and Sub‐Acute Oral Toxicity Assessment of the Methanolic Extract From Leaves of Hibiscus rosa‐sinensis L in Mice.” Journal of Intercultural Ethnopharmacology 4: 70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nayak, D. , Ashe S., Rauta P. R., and Nayak B.. 2015. “Biosynthesis, Characterisation and Antimicrobial Activity of Silver Nanoparticles Using Hibiscus rosa‐sinensis Petals Extracts.” IET Nanobiotechnology 9, no. 5: 288–293. [DOI] [PubMed] [Google Scholar]
- Ngan, L. T. M. , Tan M. T., Hoang N. V. M., et al. 2021. “Antibacterial Activity of Hibiscus rosa‐sinensis L. Red Flower Against Antibiotic‐Resistant Strains of Helicobacter Pylori and Identification of the Flower Constituents.” Brazilian Journal of Medical and Biological Research 54: e10889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noman, A. M. , Sultan M. T., Zafar S., et al. 2025. “Thymol and Carvacrol: Molecular Mechanisms, Therapeutic Potential, and Synergy With Conventional Therapies in Cancer Management.” Food Science & Nutrition 13, no. 9: e70936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nwibo, D. D. , Eze M. I., and Okonkwo T. M.. 2016. “Effects of Hibiscus rosa‐sinensis Leaf Products on Haematological Indices, Lipid Profile and Hepatic Parameters of Hyperlipidemic Rat.” African Journal of Pharmacy and Pharmacology 10, no. 12: 223–229. [Google Scholar]
- Oluwamodupe, C. , Adeleye A. O., Babalola O. O., and Ottu P. O.. 2024. Investigation of Proinflammatory Genes Expression in STZ‐Induced Diabetic Rats Treated With Extract of Hibiscus rosa‐sinensis Flower.
- Parihar, A. , Dubey B. K., Basedia D. K., Patel M. K., and Shah S.. 2024. “Development and Characterization of Hair Oil for Control Hair Fall and Stimulating Hair Growth.” International Journal of Pharmacy & Life Sciences 15, no. 12: 41. [Google Scholar]
- Patrice, A. R. J. B. A. , Cabuso L., and Narvacan C. M.. 2017. “Antibacterial Activity of Ethanolic Extract of Hibiscus rosa‐sinensis Flower Against Staphylococcus Epidermidis and staphylococcus saprophyticus . Lyceum of the Philippines‐St.” Cabrini College of Allied Medicine 2, no. 2: 39–50. [Google Scholar]
- Pethe, M. , Yelwatkar S., Gujar V., Varma S., and Manchalwar S.. 2017. “Antidiabetic, Hypolipidimic and Antioxidant Activities of Hibiscus rosa Sinensis Flower Extract in Alloxan Induced Diabetes in Rabbits.” International Journal of Biomedical and Advance Research 8: 138–143. [Google Scholar]
- Pethe, M. , Yelwatkar S., Manchalwar S., and Gujar V.. 2017. “Evaluation of Biological Effects of Hydroalcoholic Extract of Hibiscus rosa Sinensis Flowers on Alloxan Induced Diabetes in Rats.” Drug Research 67, no. 08: 485–492. [DOI] [PubMed] [Google Scholar]
- Pieracci, Y. , Pistelli L., Lari M., et al. 2021. “ Hibiscus rosa‐sinensis as Flavoring Agent for Alcoholic Beverages.” Applied Sciences 11, no. 21: 9864. [Google Scholar]
- Pillai, S. S. , and Mini S.. 2018. “Attenuation of High Glucose Induced Apoptotic and Inflammatory Signaling Pathways in RIN‐m5F Pancreatic β Cell Lines by Hibiscus rosa Sinensis L. Petals and Its Phytoconstituents.” Journal of Ethnopharmacology 227: 8–17. [DOI] [PubMed] [Google Scholar]
- Priya, K. , and Sharma H. P.. 2021. “Phytochemical Analysis and Antimicrobial Activity of Hibiscus rosa Sinensis .” European Journal of Biotechnology and Bioscience 9, no. 1: 21–26. [Google Scholar]
- Raduan, S. Z. , Abdul Aziz M. W. H., Roslida A. H., Zakaria Z. A., Zuraini A., and Hakim M. N. 2013. “Anti‐Inflammatory Effects of Hibiscus rosa‐sinensis L. and Hibiscus rosa‐sinensis Var. Alba Ethanol Extracts.” International Journal of Pharmacy and Pharmaceutical Sciences 5, no. 4: 754–762. [Google Scholar]
- Rajavelu, I. , and Bs R.. 2024. “Apoptosis Induction by Plectranthus Amboinicus and Hibiscus rosa‐sinensis Extracts in HepG2 Cells: Insights Into Cytotoxicity and Gene Regulation.”
- Rajendran, A. , Siva E., Dhanraj C., and Senthilkumar S.. 2018. “A Green and Facile Approach for the Synthesis Copper Oxide Nanoparticles Using Hibiscus rosa‐sinensis Flower Extracts and It's Antibacterial Activities.” Journal of Bioprocessing and Biotechniques 8, no. 3: 324. [Google Scholar]
- Rakhi, A. R. , Jacob I. S., Juno S., Nair K. R., Pooja S., and Anjana A. K.. 2022. “Pathological and Pharmacological Review of Liver.” World Journal of Pharmaceutical Research 11, no. 4: 1943–1955. [Google Scholar]
- Ralte, L. , Sailo H., and Singh Y. T.. 2024. “Ethnobotanical Study of Medicinal Plants Used by the Indigenous Community of the Western Region of Mizoram, India.” Journal of Ethnobiology and Ethnomedicine 20, no. 1: 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rassem, H. H. , Khamidun M. H. B., Ali U. F. M., Hadibarata T., and Alrabie N. A.. 2024. “Comprehensive Analysis of Antioxidant and Antibacterial Activities of Water and Methanol Extracts of Hibiscus Flower.” Journal of King Saud University, Science 36, no. 11: 103506. [Google Scholar]
- Raza, H. , Sultan M. T., Khalid S., et al. 2025. “Ultrasound‐Assisted Extraction of Hibiscus rosa‐sinensis Extracts for the Development of Functional Tea.” Ultrasonics Sonochemistry 122: 107628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rehana, D. , Mahendiran D., Kumar R. S., and Rahiman A. K.. 2017. “Evaluation of Antioxidant and Anticancer Activity of Copper Oxide Nanoparticles Synthesized Using Medicinally Important Plant Extracts.” Biomedicine & Pharmacotherapy 89: 1067–1077. [DOI] [PubMed] [Google Scholar]
- Rehman, M. U. , Nisar B., Yatoo A. M., et al. 2024. “After Effects of Pharmaceuticals and Personal Care Products (PPCPs) on the Biosphere and Their Counteractive Ways.” Separation and Purification Technology 342: 126921. [Google Scholar]
- Rengarajan, S. , Melanathuru V., Govindasamy C., Chinnadurai V., and Elsadek M. F.. 2020. “Antioxidant Activity of Flavonoid Compounds Isolated From the Petals of Hibiscus rosa Sinensis.” Journal of King Saud University, Science 32, no. 3: 2236–2242. [Google Scholar]
- Rose, L. C. , Rusdi N. N. S., Asari A., Abd Wahid M. E., and Suhaimi H.. 2020. “Potential Hair Growth of Crude Extract From Hibiscus rosa‐sinensis Linn.” Archives of Pharmacy Practice 11, no. 4–2020: 13–19. [Google Scholar]
- Ruban, P. , and Gajalakshmi K.. 2012. “In Vitro Antibacterial Activity of Hibiscus rosa–Sinensis Flower Extract Against Human Pathogens.” Asian Pacific Journal of Tropical Biomedicine 2, no. 5: 399–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sachdewa, A. , and Khemani L. D.. 2003. “Effect of Hibiscus rosa Sinensis Linn. Ethanol Flower Extract on Blood Glucose and Lipid Profile in Streptozotocin Induced Diabetes in Rats.” Journal of Ethnopharmacology 89, no. 1: 61–66. [DOI] [PubMed] [Google Scholar]
- Sachdewa, A. , Nigam R., and Khemani L. D.. 2001. “Hypoglycemic Effect of Hibiscus rosa Sinensis L. Leaf Extract in Glucose and Streptozotocin Induced Hyperglycemic Rats.” Indian Journal of Experimental Biology 39, no. 3: 284–286. [PubMed] [Google Scholar]
- Sağlam, A. , Özüsağlam M. A., and Çelik I.. 2023. “Determination of Antimicrobial Activity of Cream Formulation Developed With Hibiscus rosa‐sinensis Extract and Probiotic.” Manas Journal of Agriculture, Veterinary and Life Sciences 13, no. 2: 126–132. [Google Scholar]
- Sahu, C. R. 2016. “Mechanisms Involved in Toxicity of Liver Caused by Piroxicam in Mice and Protective Effects of Leaf Extract of Hibiscus rosa‐sinensis L.” Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 9: S29463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanadheera, S. , Subasinghe D., Solangaarachchi M. N., Suraweera M., Suraweera N. Y., and Tharangika N.. 2021. “ Hibiscus rosa‐sinensis L.(Red Hibiscus) Tea, Can It be Used as A Home‐Remedy to Control Diabetes and Hypercholesterolemia?” Biology, Medicine, & Natural Product Chemistry 10, no. 1: 59–65. [Google Scholar]
- Sattar Ali, Z. 2022. “Hepatic Impact of Different Concentrations of Hibiscus Rosa Zinc Oxide Nanoparticles on Rats.” Archives of Razi Institute 77, no. 3: 1199–1206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sawarkar, A. , Jangde C. R., Thakre P. D., Kadoo R., and Shelu S.. 2009. “Analgesic Activity of Hibiscus rosa Sinensis Linn in Rat.” Veterinary World 2: 353–354. [Google Scholar]
- Seyyednejad, S. M. , Koochak H., Darabpour E., and Motamedi H.. 2010. “A Survey on Hibiscus rosa—Sinensis, Alcea rosea L. and Malva neglecta Wallr as Antibacterial Agents.” Asian Pacific Journal of Tropical Medicine 3, no. 5: 351–355. [Google Scholar]
- Shafiq, N. , Yasmin F., Noreen S., Shahzad A., Rashid M., and Bilal M.. 2021. “Phytochemical Profiling of Medicinal Plants Extracts and Their Antioxidant and Anticancer Potentialities Against Human Liver cancer (Hep g2) Cell Lines.” Revista de Chimimie 72, no. 2: 1. [Google Scholar]
- Shah, F. , and Wu E.. 2019. “Soil and Crop Management Strategies to Ensure Higher Crop Productivity Within Sustainable Environments.” Sustainability 11, no. 5: 1485. [Google Scholar]
- Shaheen, S. , Khalid S., Siqqique R., et al. 2023. “Comparative Taxonomical, Biological and Pharmacological Potential of Healthy and Geminivirus Infected Leaves of Hibiscus rosa‐sinensis L.: First Report.” Microbial Pathogenesis 185: 106428. [DOI] [PubMed] [Google Scholar]
- Sharma, K. R. , and Thakur K.. 2022. “Determination of Phenolic and Flavonoid Content, Antioxidant and α‐Amylase Inhibitory Activity of Leaf and Flower Extracts of Clerodendrum Infortunatum and Hibiscus rosa Sinensis Growing in Bara Nepal.” Journal of Balkumari College 11, no. 1: 20–26. [Google Scholar]
- Sharma, P. , Rajput A., Kumar N., et al. 2023. “Antioxidant Activity and Inhibitory Potential of Hibiscus rosa‐sinensis Flower Extract Against the Key Enzymes Relevant for Hyperglycemia: In‐Vitro and In‐Silico Studies.” Minerva Biotechnology & Biomolecular 35, no. 2: 90. [Google Scholar]
- Sheikhar, C. , Rani R., Singh A. P., and Singh A. P.. 2024. “Evaluation of Anti‐Depressant Activity of Hibiscus rosa Sinensis Leaves in Mice.” Journal of Drug Delivery & Therapeutics 14, no. 12: 38. [Google Scholar]
- Shen, H. , Zheng Y., Chen R., Huang X., and Shi G.. 2021. “Neuroprotective Effects of Quercetin 3‐O‐Sophoroside From Hibiscus rosa‐sinensis Linn. On Scopolamine‐Induced Amnesia in Mice.” Journal of Functional Foods 76: 104291. [Google Scholar]
- Shewale, P. B. , Patil R. A., and Hiray Y. A.. 2012. “Antidepressant‐Like Activity of Anthocyanidins From Hibiscus rosa‐sinensis Flowers in Tail Suspension Test and Forced Swim Test.” Indian Journal of Pharmacology 44, no. 4: 454–457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shi, B. , Wang H., Nawaz A., et al. 2024. “Dual Functional Roles of Nutritional Additives in Nutritional Fortification and Safety of Thermally Processed Food: Potential, Limitations, and Perspectives.” Comprehensive Reviews in Food Science and Food Safety 23, no. 1: e13268. [DOI] [PubMed] [Google Scholar]
- Sidhu, R. , Kaushal S., Kaur V., and Sharma P.. 2023. “Chemical Composition, Synergistic Antimicrobial and Antioxidant Potential of Hibiscus rosa‐sinensis L. Leaves Essential Oil and Its Major Compound.” Journal of Essential Oil Bearing Plants 26, no. 2: 469–485. [Google Scholar]
- Sikarwar Mukesh, S. , and Patil M. B.. 2011. “Antihyperlipidemic Effect of Ethanolic Extract of Hibiscus rosa Sinensis Flowers in Hyperlipidemic Rats.” RGUHS Journal of Pharmaceutical Sciences 1, no. 2: 117–122. [Google Scholar]
- Silva, T. L. , Afiune L. A. F., de Moraes Souza R. Q., et al. 2015. “Effect of Hibiscus rosa Sinensis Aqueous Extract Treatment on Biochemical Parameters in Diabetic Pregnant Rats.” Diabetology & Metabolic Syndrome 7: 1.25810781 [Google Scholar]
- Singaravelan, K. , Krishnamoorthi G., Jeevanantham V., and Muralidharan V. P.. 2024. “Antibacterial and Methylene Blue Dye Degradation Activity of Hibiscus rosa Sinensis Synthesized CoFe2O4 Nanocomposites.” ChemistrySelect 9, no. 41: e202402697. [Google Scholar]
- Singh, K. G. , Sonia S., and Konsoor N.. 2018. “In‐Vitro and Ex‐Vivo Studies on the Antioxidant, Anti‐Inflammatory and Antiarthritic Properties of Camellia sinensis , Hibiscus Rosa Sinensis, Matricaria chamomilla , Rosa SP., Zingiber Officinale tea Extracts.” Inflammation 49: 50. [Google Scholar]
- Sinha, A. , and Asimi O. A.. 2007. “China Rose (Hibiscus Rosasinensis) Petals: A Potent Natural Carotenoid Source for Goldfish ( Carassius auratus L.).” Aquaculture Research 38, no. 11: 1123–1128. [Google Scholar]
- Sivaraman, C. M. , and Saju F.. 2021. “Medicinal Value of Hibiscus rosa Sinensis: A Review.” International Journal of Pharmacognosy and Chemistry 2, no. 1: 1–11. [Google Scholar]
- Somchit, M. N. , Zuraini A., Tan W. P., and Cheema M. S.. 2008. “Potent Inhibition of Prostaglandin D2 Induced Inflammation by Hibiscus rosa‐sinensis Crude Extract.” Planta Medica 74: PA41. [Google Scholar]
- Soni, D. , and Gupta A.. 2011. “An Evaluation of Antipyretic and Analgesic Potentials of Aqueous Root Extract of Hibiscus Rosa Sinesis Linn. (Malvacae).” International Journal of Research in Phytochemistry and Pharmacology 1, no. 3: 184–186. [Google Scholar]
- Sruthi, T. , Rao C. K., Michael R. Z., Nissy S. M., and Prakash D. S.. 2021. “In‐Vitro Anti‐Inflammatory and Anti‐Arthritic Activity of Ethanolic Extract of Hibiscus Rosa Sinensis Leaves.” Rasayan Journal of Chemistry 14, no. 4: 2279–2284. [Google Scholar]
- Sucharitha, M. , and Nagamani M.. 2021. “Evaluation of Anti‐Depressant Property of Hibiscus Rosasinensis Plant Extracts.” International Journal of Pharma and Bio Sciences 11, no. 3: 97–103. [Google Scholar]
- Surya, S. , Kumar G. D., and Rajakumar R.. 2016. “Green Synthesis of Silver Nanoparticles From Flower Extract of Hibiscus Rosa‐Sinensis and Its Antibacterial Activity.” International Journal of Innovative Research in Science, Engineering and Technology 5, no. 4: 5242–5247. [Google Scholar]
- Tawfeeq, A. A. , Tawfeeq T. A., Abaas I. S., and Salah S. H.. 2024. “Mini Review: Phytochemistry and Pharmacological Activity of Hibiscus Rosa‐sinensis Plant.” Protein: Jurnal Ilmu Keperawatan Dan Kebidanan 2, no. 4: 95–101. [Google Scholar]
- Thi, H. N. , Anh T. P., Thanh H. N., et al. 2021. “Study on the Antioxidant Capacity of Hibiscus rosa‐sinensis Decoction In Vivo in Mus musculus Var. Albino.” Nauchnye Rezul'taty Biomeditsinskikh Issledovaniĭ 7, no. 2: 149–155. [Google Scholar]
- Tong, C. Y. , and Tee T. S.. 2022. “Antioxidant and Antibacterial Activities of Flower and Leaf Extracts of Hybrid, White and Orange Hibiscus (Hibiscus Rosa‐sinensis).” Strengthening Regional Collaboration in Science & Technology 112.
- Tyagi, S. , Kumar A., and Tyagi P. K.. 2017. “Comparative Analysis of Metal Nanoparticles Synthesized From Hibiscus rosa Sinesis and Their Antibacterial Activity Estimation Against Nine Pathogenic bacteria.” Asian Journal of Pharmaceutical and Clinical Research 10, no. 5: 323–329. [Google Scholar]
- Uddin, B. , Hossan T., Paul S., Ahmed T., Nahar T., and Ahmed S.. 2010. “Antibacterial Activity of the Ethanol Extracts of Hibiscus rosa‐sinensis Leaves and Flowers Against Clinical Isolates of bacteria.” Bangladesh Journal of Life Sciences 22, no. 2: 65–73. [Google Scholar]
- Udo, I. J. , Ben M. G., Etuk C. U., and Tiomthy A. I.. 2016. “Phytochemical, Proximate and Antibacterial Properties of Hibiscus rosa‐sinensis L. Leaf.” Journal of Medicinal Plants Studies 4, no. 5: 193–195. [Google Scholar]
- Umar, H. B. , Abdulkadir S., Ibrahim B., and Ibrahim H.. 2024. “Phytochemical Screening, Acute Toxicity and Antibacterial Activity of Methanolic Stem Bark Extract of Hibiscus Rosa‐sinensis .” International Journal of Emerging Multidisciplinaries: Biomedical and Clinical Research 2, no. 1: 1–18. [Google Scholar]
- Uzombah, T. A. 2022. “The Implications of Replacing Synthetic Antioxidants With Natural Ones in the Food Systems.” In Natural Food Additives. IntechOpen. [Google Scholar]
- Valdivié, M. , and Martínez Y.. 2022. “ Hibiscus rosa‐sinensis Forage as a Potential Feed for Animals: A Review.” Animals 12, no. 3: 288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vankar, P. S. , and Shukla D.. 2011. “Natural Dyeing With Anthocyanins From Hibiscus rosa Sinensis Flowers.” Journal of Applied Polymer Science 122, no. 5: 3361–3368. [Google Scholar]
- Vankar, P. S. , and Srivastava J.. 2008. “Comparative Study of Total Phenol, Flavonoid Contents and Antioxidant Activity in Canna Indica and Hibiscus rosa Sinensis: Prospective Natural Food Dyes.” International Journal of Food Engineering 4, no. 3: 1–16. [Google Scholar]
- Vasudeva, N. , and Sharma S. K.. 2008. “Post‐Coital Antifertility Activity of Hibiscus rosa‐sinensis Linn. Roots.” Evidence‐Based Complementary and Alternative Medicine 5, no. 1: 91–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Velayutham, L. , Parvathiraja C., Anitha D. C., et al. 2022. “Photocatalytic and Antibacterial Activity of CoFe2O4 Nanoparticles From Hibiscus rosa‐sinensis Plant Extract.” Nanomaterials 12, no. 20: 3668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Velayutham, L. , Parvathiraja C., Anitha D. C., et al. 2023. “Antibacterial and Photocatalytic Dye Degradation Activities of Green Synthesized Nise Nanoparticles From hibiscus rosa‐sinensis Leaf Extract.” Water 15, no. 7: 1380. [Google Scholar]
- Vignesh, R. M. , and Nair B. R.. 2018. “A Study on the Antioxidant and Antibacterial Potential of the Mucilage Isolated From Hibiscus rosa‐sinensis Linn.(Malvaceae).” Journal of Pharmacognosy and Phytochemistry 7, no. 2: 1633–1637. [Google Scholar]
- Vijayanand, P. , Jyothi V., Aditya N., and Mounika A.. 2018. “Development and Characterization of Solid Lipid Nanoparticles Containing Herbal Extract: In Vivo Antidepressant Activity.” Journal of Drug Delivery 2018, no. 1: 2908626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vijayaraj, R. , and Kumaran N. S.. 2017. “Biosynthesis of Silver Nanoparticles From Hibiscus rosa Sinensis: An Approach Towards Animicrobial Activity on Fish Pathogen aeromonas hydrophila .” International Journal of Pharmaceutical Sciences and Research 8, no. 1: 5241–5246. [Google Scholar]
- Weerasingha, W. M. R. K. S. , Chandrasiri M. H. T. K., Hewawitharana K. H. I. K., and Sampath J. K. H.. 2021. “Evaluation of Anthocyanin Extracted From Hibiscus Rosa Synesis as a Natural Food Colorant. Data‐Driven Scientific Research for Sustainable.” Innovations 10: 17–20. [Google Scholar]
- Yadav, N. , Singh Chandel S., Venkatachalam T., and Fathima S. N.. 2024. “Herbal Medicine Formulation, Standardization, and Commercialization Challenges and Sustainable Strategies for Improvement.” In Herbal Medicine Phytochemistry: Applications and Trends, 1769–1795. Springer International Publishing. [Google Scholar]
- Yahaya, N. A. , Anuar N. K., and Saidin N. M.. 2023. “ Hibiscus rosa‐sinensis Mucilage as a Functional Polymer in Pharmaceutical Applications: A Review.” International Journal of Applied Pharmaceutics 15, no. 1: 44–49. [Google Scholar]
- Yang, X. , Rajivgandhi G. N., Ramachandran G., et al. 2020. “Preparative HPLC Fraction of Hibiscus rosa‐sinensis Essential Oil Against Biofilm Forming Klebsiella pneumoniae .” Saudi Journal of Biological Sciences 27, no. 10: 2853–2862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yasin, Z. , Khan M. R., Shabbir M. A., and Israr B.. 2025. “Exploring the Therapeutic Potential of Matricaria Chamomilla and Hibiscus Rosa‐sinensis Against Diabetes Mellitus.” Pakistan Veterinary Journal 45, no. 2: 759–766. [Google Scholar]
- Yu, M. G. , Gordin D., Fu J., Park K., Li Q., and King G. L.. 2024. “Protective Factors and the Pathogenesis of Complications in Diabetes.” Endocrine Reviews 45, no. 2: 227–252. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zaki, L. H. , Mohamed S. M., Bashandy S. A., Morsy F. A., Tawfik K. M., and Shahat A. A.. 2017. “Hypoglycemic and Antioxidant Effects of Hibiscus rosa‐sinensis L. Leaves Extract on Liver and Kidney Damage in Streptozotocin Induced Diabetic Rats.” African Journal of Pharmacy and Pharmacology 11, no. 13: 161–169. [Google Scholar]
- Zemede, J. , Mekuria T., Ochieng C. O., Onjalalaina G. E., and Hu G. W.. 2024. “Ethnobotanical Study of Traditional Medicinal Plants Used by the Local Gamo People in Boreda Abaya District, Gamo Zone, Southern Ethiopia.” Journal of Ethnobiology and Ethnomedicine 20, no. 1: 28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zuhaira, S. , Naz S., and Ridzuan P. M.. 2020. “The Efficacy of Hibiscus rosa‐sinensis Leaf Extracts Against candida SPP, Causing Candidiasis.” Journal of Science and Mathematics Letters 8, no. 1: 1–5. [Google Scholar]
- Zulkurnain, E. I. , Ramli S., Ali A. A., James R. J., Kamarazaman I. S., and Halim H.. 2023. “The Phytochemical and Pharmacological Effects of Hibiscus rosa‐sinensis : A Review.” International Journal of Pharmaceutical Investigation 13, no. 3: 422. [Google Scholar]
- Zulkurnain, I. H. , Sayuti M., Kamaruzaman A. S., et al. 2025. “Synergistic Wound Healing Effects of Hibiscus rosa‐Sinensis and Centella asiatica Extracts Combination (HRSCA): In Vivo and 3D Organotypic Models.” Journal of Health Science and Medical Research 44, no. 1: 20251214. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
